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Prenatal testing: screening and diagnosis
The field of prenatal testing has rapidly developed over the past decades. Until 
1970 women would get pregnant and have babies without knowing anything 
about the health of their pregnancy or future health of their child. In the seven-
ties and eighties techniques that allowed to gain more knowledge of the (future) 
health of the baby, before birth were developed. It was these techniques that 
made the introduction of prenatal testing possible. Since the 1970’s, prenatal 
chromosomal testing has become available by means of an amniocentesis (ac) or 
chorionic villus sampling (cVS), both invasive procedures with an associated mis-
carriage risk of 1:200, or 1:300. With ac, a sample of amniotic fluid (fluid around 
the baby) is removed from the uterus. cVS removes a small sample of placenta 
tissue from the uterus. The amniotic fluid or placental tissue can be genetically 
analysed in the laboratory.
Originally, chromosomal testing was performed with karyotyping and was 
only targeted at the detection of Down’s, and later also for Edwards, and Patau 
syndrome. Down’s syndrome is the most common chromosomal abnormality 
and occurs in around 1 in 500 pregnancies in the Netherlands. From the 1970’s 
onwards, chromosomal testing has been the golden standard in prenatal chro-
mosomal testing until the introduction of first trimester screening (FtS) in the 
Netherlands in 2007. FtS, by means of the combination test, allowed pregnant 
women to screen for the presence of Down’s syndrome, Patau syndrome and 
Edwards syndrome, that is, trisomy 21, 18 and 13. Pregnant women with an in-
creased risk based on FtS have a higher probability (for example ± >1:200) of a 
child with one of these syndromes and may opt for further testing in their preg-
nancy by means of prenatal genetic testing.
Reproductive rights are relating to reproduction and reproductive health. 
The World Health Organization defines these rights as follows: Individuals or 
couples have the right of reproductive autonomy, meaning they are free to de-
cide if they want to have children, how many, the spacing between children and 
at which time in their life.
Prenatal screening programs were designed to give women more control 
over their reproductive autonomy. The goal of prenatal screening is thus to en-
able women or couples to make informed decisions about the course of their 
pregnancy.1 Informed choice is a prerequisite for engaging in medical procedures 
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in the Netherlands. Informed choice is different from informed consent. The 
concepts of informed consent and informed choice are disentangled; informed 
consent is used to protect both patients and doctors, whereas informed choice 
is mostly used to evaluate counselling (Retel Helmrich, 2017). A choice is con-
sidered informed when there is sufficient knowledge and a consistent attitude. 
Michie et al. defined an informed choice as ‘based on relevant knowledge, con-
sistent with one’s attitudes and behaviourally implemented’ (2001).2
Informed choice is especially relevant in the l field of prenatal testing and 
screening and is viewed as very important for coping with the test results. In the 
case of a pregnant woman engaging in prenatal screening, her choice would be 
considered informed if she knows what the aim of prenatal screening is, if she 
has knowledge about the test and its’ characteristics, the possible outcomes, if 
she has deliberated whether or not the information that FtS might generate is 
important to her, and if she consequently decides to engage in FtS or not.
Before 2014
Before 2012, chromosomal testing was performed with conventional karyotyp-
ing at a resolution of 5–10 megabases (Mb) for all indications. Since 2012, the 
Erasmus Medical Center has replaced karyotyping with microarrays (single nu-
cleotide; Snp array) at 0.5 Mb resolution.3 Snp array allows for the detection of 
microdeletions and duplications at a very detailed level. As a metaphor, one could 
compare the level of detail with the mere design of a book case. With karyotyping 
you look at the bookcase from a distance. You can see the shelves and whether 
they are filled with books, but you cannot see the books separately, nor read the ti-
tles. With microarray, you stand very close to the bookcase. You see the individual 
books and you can even read the titles. Using the same metaphor, with karyotyp-
ing you can see whether shelves are missing or empty, whereas with microarrays 
you can see whether individual books are missing and even read their titles. Thus, 
microarray yields much more information about the health of the unborn child.
A next step would be next generation sequencing (exome or genome se-
quencing) which metaphorically speaking would mean that we read the books 
and determine whether text is correct.
Erasmus Medical Center offers microarray to all pregnant women engaging 
in prenatal diagnosis as a first-tier follow-up genetic test after abnormal first tri-
mester screening results.3 This broad scope microarray is only available when 
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performing invasive prenatal diagnosis by means of an amniocentesis or chori-
onic villus sampling with an associated miscarriage risk.
After 2014
Since 2014, non-invasive prenatal testing (nipt) has been introduced in the 
Netherlands. With nipt, it is possible to test with a high probability (92–99% 
certainty) for trisomies 21, 18 and 13 at no risk of a miscarriage.4 nipt has a reso-
lution of ±20 Mb, which is less detailed than karyotyping and microarray. Thus, 
it provides less genetic information about the fetus when compared to nipt is 
offered as an alternative for invasive pnd. Pregnant women with an increased 
risk based on FtS could opt for either nipt or invasive pnd as a follow-up genetic 
test. The Erasmus Medical Center had a different policy regarding invasive pre-
natal testing than the other genetic centers in the Netherlands. Whereas other 
academic centers in the Netherlands performed only Quantitative Fluorescence-
Polymerase Chain Reaction (QF-pcr) on fetal dna to examine chromosomes 13, 
18 and 21, we perform high resolution Snp array at 0.5 Mb to analyze all chromo-
somes at a submicroscopic level. The Erasmus Medical Center has completely 
replaced karyotyping by a whole genome Snp array for all indications since July 
2012. Snp array is faster and less costly than karyotyping, but most importantly; 
it provides much more detailed additional information on other chromosomal 
aberrations. The broader scope of possible outcomes requires more extensive 
pre-test counselling to enable informed decision-making.
Consequences of a broader scope
The increasing scope of possible findings provided by Snp array and nipt com-
plicates sound prenatal genetic counselling and may subsequently influence the 
pregnant couple’s informed decision-making process negatively.5 As techniques 
in the prenatal field are developing rapidly, concerns were raised about the attain-
ability of informed choice due to the more complex information women or couples 
are presented during counselling.6–9 An informational overload could put burden 
on pregnant women and couples, and the information might hinder instead of 
promoting reproductive autonomy.10, 11 It is voiced that the informational over-
load could lead to anxiety, heightened levels of stress and doubts which might 
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put further psychological burden on pregnant women or couples. Moreover, the 
complexity of information challenges the communicational skills of counsellors 
and might tread heavily on the principle of shared decision-making.
For this reason, the research described in this thesis focuses on the increased 
scope of prenatal genetic testing and on the psychological consequences for 
pregnant women or couples.
Aim and research questions
The aim of this thesis is to address the psychological consequences of the intro-
duction of new techniques in prenatal testing for pregnant women or couples 
which as a consequence may lead to the identification of many more clinically 
relevant findings with which couples have to deal with. The option of micro array 
testing in a prenatal setting has been left unexplored so far and has not yet been 
evaluated in earlier studies. Part 1 of this thesis addresses the preferences of preg-
nant women or couples regarding the scope of invasive prenatal diagnosis, in the 
pre-nipt era. The psychological consequences, such as anxiety and doubts of a 
broader scope and level of informed choice are studied. Part 2 of this thesis fo-
cuses on the psychological consequences of the additional, non-invasive option 
of nipt, and on the level of informed choice. Finally, it was explored whether the 
preference of counsellors regarding testing options affected the decision-making. 
This led to the following research questions:
Part 1: Era before NIPT was introduced, solely invasive PND
1. What do pregnant women or couples choose; a broad or narrow scope of 
microarray regarding invasive pnd? (Chapter 2)
2. Do they wish to be informed of uncertain outcomes?
3. Are there differences between participants opting for broad or narrow 
microarray regarding: the level of informed choice, anxiety and doubts? 
(Chapter 3)
4. What is the psychological impact on parents of receiving uncertain out-
comes from invasive prenatal diagnosis? (Chapter 4)
13
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Part 2: Era after introduction of NIPT
1. What do pregnant women or couples choose; nipt or invasive pnd? 
(Chapter 5)
2. Are there differences between participants opting for nipt or pnd regarding: 
the level of informed choice, anxiety and doubts? (Chapter 5)
3. Are there differences between women or couples who are counselled in 
non-academic vs. academic hospitals regarding their choices for nipt or 
pnd? (Chapter 5)
4. Do counsellors differ in the content and approach of their counselling re-
garding the level of information-centeredness, patient-centeredness, and 
the level of non-directivity? (Chapter 6)
5. Does the counsellor preference for nipt/pnd affect patients’ choice? 
(Chapter 6)
a. Were patients aware of the counsellor’s preference?
b. Were there differences in patients’ knowledge and attitude scores 
between counsellors?
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Abstract
Genomic array detects more pathogenic chromosomal aberrations than conven-
tional karyotyping (cK), including genetic variants associated with a susceptibil-
ity for neurodevelopmental disorders; susceptibility loci (Sl). Consensus regard-
ing the scope of invasive prenatal diagnosis (pnd) pregnant couples should be 
offered is lacking. This study examined pregnant couples’ preferences, doubts 
and satisfaction regarding the scope of invasive pnd.
Eighty-two couples choosing prenatal screening (pnS) and 59 couples choos-
ing invasive pnd were offered a choice between 5 Mb (comparable to cK) and 
0.5Mb resolution array analysis outcomes, the latter with or without reporting Sl. 
A pre-test self-report questionnaire and post-test telephone interview assessed 
their choices in-depth.
Actual (pnd) and hypothetical (pnS) choices differed significantly (p < 0.001). 
Ninety-five percent of the couples in the pnd group chose 0.5Mb array, versus 
69% in the pnS group. Seven percent of the pnd group wished not to be informed 
of Sl. Ninety percent was satisfied with their choice and wished to decide about 
the scope themselves. Pregnant couples wish to make their own choices regard-
ing the scope of invasive pnd. It therefore seems justified to offer them a choice 
in both the resolution of array and disclosure of Sl.
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Introduction
Genomic array analysed at high resolution detects more pathogenic anomalies 
compared to conventional karyotyping (cK) (resolution 5–10 Mb).1–4 However, it 
may also reveal pathogenic findings not related to the indication, genetic vari-
ants with incomplete penetrance and variable phenotype associated with a sus-
ceptibility for neurodevelopmental disorders; susceptibility loci (Sl) or variants 
of unknown significance (VouS).5 Analysis with higher resolution (e.g. 0.5 Mb) 
detects common trisomies and known (micro)deletion/duplication syndromes 
that match the indication, but also potentially reveal more unexpected diagnoses 
and uncertain results such as Sl than cK (resolution 5–10 Mb). The advantages 
of Snp array in invasive pnd are evident for pregnancies with ultrasound anoma-
lies,1, 2 but the implementation of Snp array in invasive pnd for other indications 
has raised concerns among professionals.6–9
First, informed consent is believed to be untenable due to the higher inci-
dence of findings not related to the indication.6, 10 Some have argued that array 
might complicate informed decision-making.6, 7, 8, 11 Generic consent has been 
proposed as an alternative,6, 11 which we temporarily implemented by offering 
pregnant couples a choice between predefined categories of genetic outcomes 
when we started using Snp array in case of ultrasound anomalies.12 However, 
whether generic consent will provide sufficient basis for decision-making has 
not yet been established. Second, first trimester screening (FtS) is intended to 
identify pregnancies at risk for the most common aneuploidies (Down, Edwards 
and Patau syndrome), while Snp array as a follow-up test may detect many more 
genetic aberrations for which the a priori risk is not increased.13
Third, when using Snp array, genetic variants associated with susceptibility 
for neurodevelopmental disorders such as developmental delay, and/or behav-
ioural/learning problems, autism spectrum disorders or seizures are found in 
about 1% of pregnancies without foetal ultrasound anomalies.1, 2 If found pre-
natally, the risk of developing the disorder is not yet quantifiable. The phenotype 
of the foetus is difficult to assess due to phenotypic heterogeneity of the carriers 
and functional and some structural foetal anomalies cannot be detected by ultra-
sound examination. The phenotype may vary from normal to severely affected, 
probably depending on a second hit14 or genetic/environmental background. 
Thus, the use of array also ensues the dilemma whether to inform pregnant 
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couples of Sl or not. It has been argued that pregnant couples may not wish to be 
informed of findings of uncertain nature3 and that such findings should be with-
held in order not to put burden on the pregnant couple.15, 16 On the other hand, it 
has been proposed that couples should be informed of any finding in order to be 
able to exert their reproductive autonomy8 and that better tools for dealing with 
uncertainty should be developed.9, 15, 17, 18
Previous research on patients’ choices has demonstrated quite consistently 
that when offered a choice regarding the number of genetic conditions tested in 
one test, pregnant couples preferred a maximum of conditions.19, 20 However, 
the latter study concerned hypothetical preferences and did not concern Snp ar-
rays. Remarkably, few studies investigated the actual choices concerning inva-
sive prenatal testing in a real-life setting.
The aim of this study was to investigate whether pregnant couples at increased 
risk for an aneuploidy prefer 5 or 0.5Mb array, to assess whether couples who en-
gage in pnS or pnd differed in this choice (theoretical vs. actual choice) and to 
assess whether pregnant couples wished to be informed about uncertain infor-
mation such as Sl. Additionally, we investigated whether participants opting for 
higher resolution experienced more doubts regarding their choice and whether 
participants were satisfied regarding their choice four weeks after the test result.
Materials and methods
Participants
Pregnant women or couples were approached from February 2012 to September 
2013 in the clinic of the department of prenatal medicine in the Erasmus Medical 
Center in Rotterdam, the Netherlands. We included partners of pregnant wom-
en since we were interested in both partners’ decision processes. Other studies 
focused mainly on pregnant women. This study was exempted by the medical 
ethical committee of the Erasmus University Rotterdam. Inclusion criteria for 
participation were a) increased risk on common trisomies (advanced maternal 
age (ama), increased risk based on FtS or combined indication), b) the woman 
or couple was participating in first-trimester prenatal screening (pnS) or invasive 
prenatal diagnosis (pnd) and c) fluency in Dutch language. The exclusion crite-
ria were a) presence of ultrasound anomalies and/or b) language barriers. The 
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sample (N = 250) consisted of 141 female and 109 male participants (see Figure 1 
and 2). Women were approached at the intake of their first ultrasound, around 
9–11 weeks gestational age (Ga) and counselled by a clinical geneticists (togeth-
er with partner), after which both pregnant women and their partners filled out 
questionnaires individually. Between 16–23 weeks Ga, participants were ap-
proached for follow-up by phone. See Figure 3 for a timeline of the study.
Methods
An information leaflet about the study was added to the invitation letter pregnant 
women received before attending the outpatient clinic. A research-assistant was 
present at the clinic to approach pregnant couples meeting the inclusion criteria 
and provide information concerning the study and its further procedure. After 
consenting, an additional genetic counselling with a clinical geneticist by tele-
phone was planned in in advance of the next appointment for pnS or pnd in order 
to enable informed decision-making. Face-to-face counselling was not practical-
ly feasible in this study.
Counselling
We offered participants a choice between a Snp array analysed at 5 Mb resolu-
tion (comparable to cK) and a Snp array analysed at 0.5 Mb resolution (higher 
resolution). Participating couples received counselling from (or under the su-
pervision of ) a clinical geneticist by telephone. Extensive information was pro-
vided. In addition to the background of genetics, participants were informed of 
the difference between 5 Mb resolution and 0.5 Mb resolution. Examples of what 
could be detected additionally by 0.5 Mb testing over 5 Mb testing was illustrated 
with Wolf-Hirschhorn syndrome, Duchenne muscular dystrophy and examples 
of Sl. Sl were explained as ‘risk factors’, genetic variants that give an elevated 
but unquantifiable chance on mainly neurodevelopmental disorders, such as au-
tism, learning disabilities, epilepsy and/or psychiatric disorders. The geneticist 
explained these ‘risk factor variants’ could occur in both healthy and affected in-
dividuals and that they have a variable expression, ranging from no expression at 
all to severe expression.
Five Mb resolution array was presented as a ‘narrower test’ and it was speci-
fied that trisomy 13, 18 and 21 and other microscopically visible deviations could 
be found. The last part of the counselling consisted of a dialogue about the 
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couples’ concerns, questions and preferences. Couples were asked whether they 
already knew what test they preferred and whether they needed additional in-
formation to make a decision. Within three days after counselling but before their 
pnd or pnS appointment, all participants filled out a questionnaire individually.
Participants engaging in pnd were contacted by the researcher one day be-
fore their appointment to ascertain their choice (0.5 Mb or 5 Mb analysis). The 
laboratory was informed of the couples’ choice and performed their array resolu-
tion of choice. Participants engaging in pnS and not proceeding with pnd made 
a hypothetical choice. pnS participants filled out the questionnaire hypothetical-
ly, they were asked ‘If you should engage in invasive pnd by means of amnio-
centesis or chorionic villus sampling, what array resolution would you choose?’. 
Then, the pnS group filled out the same questions as participants in the pnd 
group, while keeping their hypothetical choice for the array resolution in mind. 
Additionally, if participants in the pnS group were undecided, they could opt for 
‘I cannot choose’.
Data
Socio-demographic data were collected, see Table 1. Pregnant couples’ choices 
and willingness to choose between 0.5 and 5 Mb array pnd were assessed (options: 
‘I want to decide myself ’, ‘I think the doctor should decide’, ‘I want to make a de-
cision in consultation with the doctor’ or ‘I do not have an opinion about this’). 
One question assessed whether pregnant couples would be interested in whole 
exome sequencing (WeS) in the near future (‘If there would be a test that could 
detect even more anomalies, do you feel this test should be offered?’, options 
of answer: yes/no/no opinion). Furthermore, the questionnaire comprised the 
Decisional Ambivalence Scale (daS) which was designed for this study. The daS 
measured doubt or confidence regarding the choice with ten items (see Table 2). 
All items had a 10-point response format and ranged from 1 (not at all) to 10 (very 
much so). daS total score ranged 10–100, a higher score indicated a higher level 
of experienced doubts.
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Statistical analyses
Before analysing the data for this study, assumptions for anoVa were checked. 
A significance level of p <0.05 was used for all analyses. Outliers were detect-
ed, reverse-scored items were recoded and total scores have been calculated. 
To validate the instruments, Cronbach’s alpha was used to examine the inter-
nal consistency of the daS. To assess if there was a relationship between back-
ground variables and the choice of test separate Pearson’s Chi-square tests were 
performed. To assess whether the choice for 5 or 0.5 Mb differed between the 
pnS and pnd group a Pearson Chi-square test was used. We performed Pearson’s 
Chi-square tests on socio-demographic data to determine whether we could an-
alyse the results for the pnS and pnd group as a whole (to test if background var-
iables differed in the pnS and pnd group). A one-way anoVa was performed to 
assess if level of doubt differed between educational level. To assess whether the 
choice for 5 or 0.5 Mb differed between educational level a Pearson’s Chi-square 
test was used. A one-way anoVa was performed to assess whether 0.5/5 Mb ar-
ray analysis and pnS/pnd differed in levels of experienced doubts on t0 (after 
the counselling, but before their first appointment for pnd or pnS) and t1 (four 
Items Mean SD
a. I have made the right choice about the test 8.39 1.55
b. I accept the consequences of my choice 8.73 1.52
c. I am happy to make this choice myself 8.84 1.36
d. I have doubts about my choice 3.06 2.36
e. I am worried about the possible consequences of my choice 4.65 2.82
f. I would prefer the doctor to make this choice 2.07 1.81
g. My partner supports me in this choice 9.15 1.71
h. The choice I have made, feels like my own choice 8.94 1.66
i. My choice seemed to have the doctors preference 3.21 2.49
j. I have had sufficient information to make my choice 8.25 1.78
Table 2. Items and Range of Decisional Ambivalence Scale.
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weeks after their test result). Furthermore, correlation between choice and level 
of doubt was calculated. Lastly, we assessed whether pregnant couples were sat-
isfied with their choice for the array resolution four weeks after their test results. 
iBm SpSS Statistics 21.0.0.1 was used to analyse data.
Results
Women’s mean age was 37.7 (Sd = 3.1) and men’s 39.8 (Sd = 5.6) years. Internal 
consistency of the daS was α = .85 in a sample of 250 participants.
There was a significant association between the test type (pnS/pnd) and al-
ready having children (χ²(4) = 9.65, p < 0.05), as well as the test type (pnS/pnd) 
and the indication (χ²(3) = 34.00, p < 0.001), see Table 1. Pregnant couples who 
already had children opted for invasive pnd more often, as well as women with 
an ama indication. Furthermore, there was a significant association between the 
choice of array resolution (5 Mb/0.5 Mb) with indication (χ²(9) = 18.96, p < 0.05) 
and with test type (pnS/pnd), (χ²(3) = 45.18, p < 0.001). Pregnant women with an 
ama indication opted for 0.5 Mb more often, as well as for invasive pnd.
There were no other significant differences regarding the socio-demographic 
and obstetric background variables, see Table 1.
Pregnant couples’ decisions regarding the choice of test
Seventy-nine percent of the participants wished to decide about the scope of 
invasive prenatal testing solely themselves, 19% wished to decide about this in 
consultation with a doctor whereas 1% wished the doctor to decide for them 
(1% missing).
Ninety-four per cent of the pnd group and 69% of the pnS group chose testing 
at higher resolution (0.5Mb array), and of these groups 84% and 44% resp. wished 
to be informed of Sl if detected (see Figure 4 and 5). The pnd group chose 0.5 
Mb Snp array analysis significantly more often, χ²(2) = 18.49, p < 0.001, and also 
chose to be informed of Sl significantly more often, χ²(2) = 44.79 , p < 0.001. In 
the pnS group, 7% of the participants was unable to make a hypothetical choice.
Seventy-eight percent of all participants appreciated the option of whole ex-
ome sequencing (WeS) in the near future. Only 8% would not like to know as 
much as possible and 14% did not have an opinion about WeS.
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11%
5%
84%
44%
7%
24%
25%
Figure 4. Actual choice of all participants in the invasive prenatal diagnosis group.
Figure 5. Hypothetical choice of all participants in the prenatal screening group.
Choice
0.5Mb − SL
5Mb
0.5Mb + SL
Choice
0.5Mb − SL
5Mb
Can not choose
0.5Mb + SL
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Educational level
We identified three levels of education; low (primary to low secondary educa-
tion), intermediate (higher secondary to low tertiary education) and high (bach-
elors, masters and above). A one-way anoVa was performed to test if level of 
experienced doubts (t0 and t1) differed between educational level. There was 
no significant effect of educational level on level of experienced doubts nor in 
choice of array resolution.
PNS vs. PND group
The pnS and pnd group did not significantly differ in level of doubts.
0.5 Mb vs. 5 Mb
There was a significant effect of choice on t0 doubts, F (3,239) = 3.76, p<.05. The 
5 Mb group (M = 35.10, Sd = 9.80) experienced significantly more doubts on t0 
than the 0.5 Mb group (M = 30.44, Sd = 9.21). The correlation between choice of 
test and level of doubts was R = 0.046, r = 21, p<.05, showing a significant, small 
to medium positive relationship. On t1 (four weeks after the test result) this effect 
was not significant.
Of all participants, 90% was satisfied with their choice, however 27% of these 
had doubts and 19% was worried about the possible consequences of their deci-
sion four weeks after the test result.
Discussion
Since the availability of prenatal whole genome Snp array analysis, there is much 
discussion whether this genetic test should be offered to pregnant couples for 
other indications than foetal ultrasound anomalies. The aim of this study was to 
investigate the real-time diagnostic preferences of pregnant couples at increased 
risk for common trisomies.
Both the pnS and pnd group preferred broad scope testing, which is congru-
ent with earlier findings.7 It seems that the pregnant couples are not withheld 
in their choice by concerns voiced by professionals in the field such as the right 
to self-determination, the right not to know etc.6–8 Since the majority of the 
pnS group also preferred higher resolution testing, it would seem that it is not 
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just the miscarriage risk of invasive testing that prompted pregnant couples to 
want to learn as much as possible about the (future) health of their unborn child. 
Pregnant couples may have a greater information need than what is commonly 
offered. It is important to emphasise that pregnant couples appreciated being of-
fered a choice, which is consistent with our 21 and other’s experience.7, 22 Several 
studies have previously demonstrated that professionals were more conservative 
than pregnant couples with regard to what pnd should detect.7, 23 An earlier study 
explored the views and preferences of professionals and potential users concern-
ing pnd.7 In this study, most potential users and midwives preferred individual-
ised choice in pnd, whereas physicians (gynecologists, clinical geneticists and 
cytogeneticists) would prefer rapid aneuploidy detection (rad) for efficiency 
and financial reasons. In congruence, we were also more conservative than the 
pregnant couples since we anticipated that couples would decline Sl, because 
knowledge of Sl might lead to increased stress and worries.6, 8, 16 It was striking 
that most pregnant couples wished to be informed of the presence of Sl should 
these be detected. Apparently, pregnant couples value information to the extent 
that they are willing to bear the uncertainty caused by Sl. In our sample none of 
the couples received an Sl as a test outcome. Thus, it was not possible to reflect 
on how couples dealt with Sl in the current study. In due course we will report on 
the psychological impact of uncertain outcomes such as Sl.
Most of the research into broadening the scope of pnd concerned hypotheti-
cal choices.19 In the only two studies offering a real choice, pregnant couples pre-
ferred cK over targeted testing for common occurring aneuploidies (rad stand-
alone).20, 22 The current study is unique in offering pregnant couples an actual 
choice between 5 Mb (comparable to cK) and 0.5 Mb array resolution analysis. 
Couples who made a real-time choice more often chose for higher resolution ar-
ray, thus, our outcomes suggest that a hypothetical choice may not be a good pre-
dictor of the choice couples make once they actually engage in pnd.
Although most participants were satisfied with their choice, about one third 
of these reported doubts or feelings of worry regarding this choice. Couples 
opting for the higher resolution experienced less doubts regarding their choice 
than did couples opting for a lower resolution. These couples may have felt more 
reassured that severe genetic anomalies would not be missed. In contrast, cou-
ples opting for a lower resolution analysis may already have been more doubtful 
about the possible outcomes of prenatal genetic testing. Alternatively, it may be 
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that the doubts pregnant couples experienced in our sample are influenced by 
the degree of informed decision-making, since making uninformed decisions is 
associated with experiencing psychological distress.24
Although the pnd group almost unanimously opted for 0.5 Mb array analy-
sis, most also indicated that they wished to decide about the scope of pnd them-
selves. Thus, instead of suggesting it may be justified to merely offer 0.5 Mb array 
analysis in pregnancies without ultrasound anomalies, we suggest that couples 
should be offered a choice regarding the scope of invasive pnd. We realise that 
offering this choice is not only a challenge for counselling and informed deci-
sion-making, but also for routine management of large numbers of patients. It 
may become necessary to start offering and counselling these options earlier in 
pregnancy, for example in primary care.
The current study had a number of limitations and strengths. A limitation in 
this study was the non-random, observational design and a homogeneous group 
of participants. The great strength of our study was that we were able to assess 
the actual choices of couples engaging in invasive pnd.
Conclusion
In conclusion, offering pregnant couples an individualised choice regarding the 
scope of invasive pnd seems an appropriate approach that is highly valued by 
patients. As most pregnant couples preferred a maximum of information (includ-
ing Sl) and wished to make their own decision about the scope of invasive pnd, 
we suggest that patients without ultrasound anomalies may be offered a choice 
regarding the scope of invasive pnd, including the option of a higher resolution 
array and disclosure of Sl.
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Abstract
Developments in prenatal testing allow the detection of more findings. Snp ar-
rays in prenatal diagnosis (pnd) can be analyzed at 0.5 Mb resolution, detect-
ing more clinically relevant anomalies, or at 5 Mb resolution. We investigated 
whether women had sufficient knowledge to make informed choices regarding 
the scope of their prenatal test that were consistent with their attitude. Pregnant 
women could choose between testing at 5 or at 0.5 Mb array.
Consenting women (N = 69) received pre-test genetic counselling by phone 
and filled out the Measure of Informed Choice questionnaire designed for this 
study. Choices based on sufficient knowledge and consistent with attitude were 
considered informed. Sixty-two percent of the women made an adequately in-
formed choice, based on sufficient knowledge and attitude-consistent with their 
choice of microarray resolution. Women who made an informed choice, opt-
ed for 0.5 Mb array resolution more often. There were no differences between 
women making adequately informed or less informed choices regarding level of 
experienced anxiety or doubts. Over time on t0 and t1, anxiety and doubts sig-
nificantly decreased.
While previous studies demonstrated that knowledge is an important com-
ponent in informed decision-making, this study underlines that a consistent at-
titude might be equally important for decision-making. We advocate more focus 
on attitude-consistency and deliberation as compared to only a strong focus on 
knowledge.
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Introduction
Prenatal genetic screening and follow-up diagnostic testing confront pregnant 
women with often difficult decisions. One of the first decisions women make is 
whether or not to participate in prenatal screening. When deliberating whether 
or not to participate in prenatal screening programs, many women may find it dif-
ficult to understand the characteristics of the test, to weigh its benefits and risks 
and to grasp the possible implications.1
The use of new, increasingly complex techniques, it is feared, may further 
hinder informed choices.2–4 To date, there has been little empirical evidence 
to support or falsify the concern that women may no longer be able to make in-
formed decisions regarding more complex prenatal tests. While techniques in 
prenatal screening and diagnosis are developing rapidly, the need for insight into 
whether pregnant women are making informed choices about prenatal genetic 
testing becomes ever more pressing.
The stated aim of prenatal screening is to offer reproductive options, allow-
ing pregnant women to choose the best course of action if their unborn child 
is affected.5 These actions may include preparing for the future, altering preg-
nancy management or terminating a pregnancy. Prenatal screening and di-
agnosis should thus provide information about the fetus that is relevant to re-
productive decision-making. Information that is not relevant to reproductive 
decision-making, it is argued, consequently falls outside the scope of prenatal 
screening.6 Information outside of this scope can be unwanted, for it may be 
burdensome and could lead to worry or anxiety for pregnant women. Moreover, 
such information may needlessly infringe upon their child’s right not to know its 
genetic risk.3, 6 Although the scope of prenatal screening should thus be limited 
to information that is relevant to reproductive decision-making, what is consid-
ered to be relevant is a topic for debate.
At present, in the Netherlands, prenatal screening is limited to detecting an 
increased risk of trisomies 13, 18 and 21. However, in our center we employ whole 
genome Snp arrays for prenatal diagnosis. One of the major consequences of using 
Snp array instead of more targeted techniques (such as rapid aneuploidy detection 
or conventional karyotyping) is that many more genetic aberrations may be detect-
ed (e.g., early onset diseases such as Williams syndrome, and Duchenne muscular 
dystrophy). Genetic aberrations may even include susceptibility loci (Sl: 1.4%).7 
46
chapter 3
Sl are complicated test results because although they are defined as ‘likely path-
ogenic’,8 the associated risk of expression and severity is yet unquantifiable. Sl 
are associated with neurodevelopmental disorders such as learning disabilities, 
behavioral problems and/or seizures.7, 9 We reported on the first parents’ expe-
riences with prenatal disclosure of Sl in a previous study.10 Outcomes like these 
may be equally relevant to reproductive decision-making. There is tension be-
tween the legal scope of prenatal screening in the Netherlands and its stated aim 
of enabling reproductive autonomy. There is also a tension between the scope of 
Snp array for follow-up diagnostic testing at our clinic, and the scope of screening 
in the national prenatal screening program, which is much narrower.
This contentious topic leads to much discussion amongst professionals and 
ethicists about which test to employ and what to report to pregnant women re-
garding prenatal genetic test outcomes. Some emphasize that test results which 
fall outside the scope of prenatal screening might put an unnecessary burden on 
pregnant couples,3 while others argue that withholding any kind of information 
is paternalistic and should be avoided.11
A prerequisite for reproductive autonomy is making an informed choice. 
Marteau et al. (2001) state that ‘An informed decision is one where all the avail-
able information about the health alternatives is weighed up and used to inform 
the final decision; the resulting choice should be consistent with the individual’s 
values. An effective decision is one that is informed, consistent with the decision 
maker’s values and behaviorally implemented’ (p. 100). Well-informed choic-
es are psychologically beneficial.12, 13 Psychological management of prenatal 
test decisions is better when knowledge is adequate,14 while uninformed choic-
es increase decisional conflict and decrease feelings of personal well being.15 
Psychological coping and informed choice were more difficult for pregnant wom-
en who were not prepared for the possibility of an abnormal prenatal screening 
result.16 Studies reported that a majority of pregnant women did not make in-
formed decisions regarding prenatal screening. and most women did not have 
sufficient knowledge to prepare them for the possibility of abnormal outcomes 
of prenatal screening.17, 18 Without adequate information provision and coun-
selling, offering prenatal diagnosis with a wider scope could indeed burden the 
pregnant couple and undermine their reproductive autonomy instead of enhanc-
ing it. Making informed choices is meant to prevent the harms that too much un-
wanted information could cause.
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What pregnant couples wish to learn about the health of their fetus is under-
reported thus far. The few studies on this subject indicate a preference among 
pregnant couples to learn as much as possible from prenatal diagnosis (pnd).19, 20 
We have recently reported that the vast majority of pregnant couples to whom 
we had offered the choice between array at higher (0.5 Mb) or lower resolution 
(5Mb, comparable to cK), chose higher resolution array. In our experience, most 
pregnant couples at increased risk for common aneuploidies chose to learn as 
much as possible about the (future) health of their unborn child.21 We further-
more offered couples a choice whether they wished to be informed of Sl if de-
tected. Eighty-four percent of the pregnant couples engaging in pnd chose to be 
informed of Sl should these be detected.21 Using Snp arrays as a diagnostic pre-
natal test leads to the poignant question of the extent to which pregnant couples 
have sufficient knowledge to make informed decisions regarding its scope.19
In this study we report on one member of pregnant couples, that is, pregnant 
women at increased risk for common aneuploidies who were offered a choice 
between 0.5 and 5 Mb Snp array testing. We investigated whether they had suf-
ficient knowledge to make an informed decision consistent with their attitude. 
Furthermore, we explored whether level of informed choice was associated with 
anxiety and doubts.
Materials and methods
Participants
Pregnant women (N = 69) consented to participate from February 2012 to Sep-
tember 2013 at our outpatient prenatal clinic. Inclusion criteria were: 
a. advanced maternal age (>36 years), and/or 
b. the woman participated in first-trimester prenatal screening (pnS) or pnd, 
and 
c. fluency in Dutch language. 
Women were approached at the intake of their first ultrasound, around 9–11 
weeks gestational age (Ga) and counselled by a clinical geneticist (see Figure 1 
for a timeline of the study). After counselling, women filled out a questionnaire 
about their choice. The Measure of Informed Choice, see Measures section, was 
filled out by a subsample of women that participated in our previous study.21
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Procedure
This study was waivered by the local Medical Ethical Testing Committee (metc). 
An information leaflet about the study was added to the invitation letter pregnant 
women received before attending the outpatient clinic. A research-assistant was 
present at the clinic to approach pregnant women meeting the inclusion criteria 
and provide information concerning the study and its further procedures. After 
consenting, an additional genetic counselling session with a clinical geneticist by 
telephone was planned in advance of the next appointment for pnS or pnd. We 
combined women engaging in pnS (hypothetical choice) and pnd (real choice) 
in our sample to obtain a larger number of participants. Face-to-face counselling 
was not practically feasible in this study.
Women were approached at the intake around 9–11 weeks gestational age 
(Ga) and counselled by a clinical geneticist, after which they filled out a question-
naire (t0) (see Figure 1). Between 16 and 23 weeks Ga, women were approached 
for follow-up by phone. This was four weeks after their prenatal test results (t1).
Content of genetic counselling by telephone
Participating women received a 30–45 minute counselling from a clinical genet-
icist (or a resident) by phone. Extensive information was provided. In addition 
to the background of genetics, participants were informed of the difference be-
tween 5 Mb and 0.5 Mb array. The 5 Mb array was presented as a ‘less broad test,’ 
and it was specified that trisomy 13, 18 and 21 and other microscopically visible 
deviations could be found, comparable to the scope of a karyotype. The 0.5 Mb 
array was presented as a ‘broader test,’ and examples of what could be detect-
ed additionally by broader testing compared to less broad testing was illustrated 
with Williams syndrome, Duchenne muscular dystrophy, and susceptibility loci 
for neurodevelopmental disorders (Sl); these were counselled as incidental find-
ings. Initially, participants could choose between 5 Mb testing and 0.5 Mb testing. 
The 0.5 Mb array resolution was presented as a broader test that also included 
susceptibility loci. During data collection, an increasing number of participants 
wished to learn the results of 0.5 Mb resolution array, but without disclosure of 
susceptibility loci. Therefore, we adopted the policy that participants could also 
opt for 0.5 Mb (broader testing) without being informed of susceptibility loci. The 
last part of the counselling comprised a dialogue about the women’s concerns, 
attitudes towards the scope of testing, questions and preferences. Women were 
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asked whether they already knew what resolution they would choose. If neces-
sary, additional information or explanation was provided.
Measures
Demographics
Socio-demographic data were collected (living situation, educational level, na-
tionality, religion, and age).
Measure of Informed Choice
To explore informed decision making regarding the scope of pnd, we devel-
oped the Measure of Informed Choice (mic). The mic is based on the Multi-
dimensional Measure of Informed Choice instrument [mmic, Knowledge Scale 
(α = .68), and Attitude Scale (α = .78)] by Michie, Dormandy and Marteau (2002), 
which measures knowledge and attitude towards pnS. Our mic contains 7 items 
measuring knowledge (see Table 1) and 6 attitude items regarding the scope of 
pnd (see Table 2). A decision was considered to be adequately informed if it was 
based on sufficient knowledge and if the decision was consistent with the atti-
tude towards testing with higher or lower resolution array. The knowledge scale 
comprised multiple-choice items, and we determined a cut-off score of 5 or more 
correct answers to qualify as ‘adequate knowledge’ (see Table 1). We used a very 
strict criterion because the choice we offered is controversial, and we wanted to 
maintain a high standard to evaluate our counselling. Michie et al. used a mid-
point score (4.5) on 8 knowledge questions for knowledge to be qualified as suf-
ficient. Thus, our criterion for ‘sufficient knowledge’ is stricter. This should be 
taken into account when interpreting our results.
We developed the mic questions based on the content of the counselling par-
ticipants received. During counselling, there was a strong emphasis on explain-
ing what the differences between 0.5 Mb and 5 Mb testing were, and what the 
respective scopes might and might not detect, with realistic examples of certain 
conditions. A team of clinical geneticists, psychologists and a statistician were 
involved with the development of the questions. The attitude scale comprised six 
statements with a 10-point response format and ranging from 1 (useless/not im-
portant) to 10 (very useful/very important) (see Table 2). A higher score indicat-
ed a more positive attitude towards broader scope array (0.5 Mb), a lower score 
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Item (multiple choice)
Incorrect/
correct M SD
Q1 Which conditions can be excluded by CVS or AC? 0/1 .78 .42
Q2 What is the risk of having a miscarriage? 0/1 .82 .39
Q3 Which conditions may the less broad test detect? 0/1 .50 .50
Q4 Which conditions are not detectable with the less 
broad test?
0/1 .79 .41
Q5 Which conditions may the broad test detect? 0/1 .88 .33
Q6 What is a susceptibility locus? 0/1 .53 .50
Q7 What could be the added value of the broad test for 
pregnant women?
0/1 .79 .41
Total knowledge score 0–7 4.78 2.88
Table 1. Item descriptives of mic knowledge scale, 7 items (Cronbach’s. α =.55, N = 69).
Item Range M SD
1. For me, knowledge about Down syndrome is…
a. (1) Not of added value … (10) Useful 1–10 8.86 1.64
b. (1) Unimportant … (10) Important 1–10 9.08 1.51
2. For me, knowledge about a small, but severe chromosomal abnormality is…
a. (1) Not of added value … (10) Useful 1–10 9.00 1.39
b. (1) Unimportant … (10) Important 1–10 9.04 1.46
3. For me, knowledge about a susceptibility locus is…
a. (1) Not of added value … (10) Useful 1–10 6.45 3.29
b. (1) Unimportant … (10) Important 1–10 6.66 2.97
Total attitude score 6–60 47.90 11.1
Table 2. Item descriptives of mic attitude scale (Cronbach’s. α =.78, N = 69).
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indicated a more negative attitude. Based on design of the mmic from Marteau et 
al. (2001), we created three categories of outcomes of informed choice;
1. completely informed (adequate knowledge and consistent attitude),
2. partly uninformed (poor knowledge and consistent attitude, or good knowl-
edge and inconsistent attitude) and
3. completely uninformed (poor knowledge and inconsistent attitude).
Decisional Ambivalence Scale
The questionnaire furthermore comprised the previously published Decisional 
Ambivalence Scale (daS; (Cronbach’s α = .85).21 The daS contain ten items that 
measure doubts and confidence regarding the choice. All items had a 10-point 
response format and ranged from 1 (not at all) to 10 (very much so). Summed 
scores on the daS can range from 10–100, with a higher score indicating a higher 
level of experienced doubts.
State-Trait Anxiety Inventory
Anxiety was measured using the short version of the Dutch State-Trait Anxiety 
Inventory (Stai), which was validated for pregnant women in the Netherlands.22 
The scores ranged from 1 (not at all) to 4 (very much so). Stai total scores can 
range from 20–80. Higher scores indicate greater feelings of anxiety.21
Statistical analyses
To obtain a larger sample, women engaging in pnS (hypothetical choice) and pnd 
(real choice) were both included in our analyses. It should be noted that these are 
two different groups of women, and that the pnd group is a ‘high stakes’ group 
compared to the pnS group, that has lower stakes. Women in the pnd group had 
made a real choice that led to real prenatal test results, and therefore they could 
have, arguably, paid more attention to the counselling. However, as there were 
no statistically significant differences in informed choice between the two groups 
of women, we analyzed the sample as a whole.
Before analyzing the data for this study, assumptions for anoVa were checked. 
A significance level of p < 0.05 was used for all analyses. Outliers were detected, 
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reverse-scored items were recoded, and total scores were calculated. To examine 
the internal consistency of the mic, Cronbach’s alpha was used.
To assess whether participants made an informed choice, we calculated total 
mic Knowledge and Attitude scores. Correct answers on the Knowledge scale 
were coded into dichotomous scores (1 = correct; 0 = incorrect),1 thus summed to 
a maximum of 7 points. For the Attitude scale, with six statements, scores ranged 
from 6 (very negative) to 60 (very positive). Those were summed and divided by 
6 to produce an attitude score between 1 and 10. Similar to other studies on this 
subject,13, 23, 24 we employed a midpoint score for the attitude scale; participants 
with an attitude score below 5.5 were categorized as having a negative attitude, 
scores above 5.5 were categorized as a positive attitude. Attitudes were checked 
for their congruence with the choice of array resolution. For example, if a par-
ticipant indicated that knowledge about Sl was important/useful, 0.5Mb array 
resolution including disclosure of Sl was expected as a choice. Attitudes were 
linked to choice of test for (in)consistency.
To examine the relationship between nominal variables, separate Pearson 
chi-square tests were used for decision outcome and actual (pnd) and hypotheti-
cal (pnS) choice, decision outcome and broad (0.5 Mb) or less broad (5 Mb) array, 
and for decision outcome and wanting to be informed about Sl (+Sl/-Sl).
We assessed differences in background variables (age, level of education) for 
women making an informed vs. an uninformed choice using separate Pearson 
chi-square tests.
Using the decision outcome (completely informed/uninformed) as dichoto-
mous factors, we performed separate independent samples t-tests for continu-
ous variables (Stai/daS total scores) to test for differences between groups. To 
assess differences in anxiety and doubts (daS/Stai) between women opting for 
or against disclosure of Sl, independent t-tests were performed. For anxiety and 
doubts over time (t0 & t1), we used paired samples t-tests.
Results
Demographic variables
The mean age of women was 37.9 years. The demographic variables (see Table 3) 
of women making informed or uninformed choices did not differ significantly, 
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although the relationship between educational level and informed/uninformed 
choices was marginally significant (p = 0.055).
Measure of Informed Choice
Tables 1 and 2 present the items and descriptives of the mic knowledge and atti-
tude scales. The internal consistency reliability of the mic Knowledge scale was 
α = .55, which is insufficient. This was caused by the fact that most women an-
swered the questions with the same answers, resulting in lower variances, which 
led to a lower Cronbach’s alpha. The mic Attitude scale had a reliability of α = .78.
Figure 2 shows the percentage of correct and incorrect answers for the mic 
Knowledge questions (see Table 1 for the specified questions). Most questions 
were answered correctly by the majority of women. Question 3, ‘Which diseases 
may the less broad test detect?’ and question 6 ‘What is a susceptibility locus?’ 
were answered correctly by approximately 50% of the women.
Total
N (%)
Informed
N (%)
Uninformed
N (%)
p(χ²)*
Previous children
Yes
No
42 (60)
28 (40)
25 (66)
13 (34)
17 (53)
15 (47)
.28
Education
Low-intermediate
High
25 (35)
44 (65)
12 (29)
30 (71)
12 (46)
14 (54)
.055
Nationality
Dutch
Other
64 (93)
5 (7)
38 (88)
5 (12)
26 (100)
.07
Religious
Yes
No
17 (25)
51 (75)
11 (26)
31 (74)
6 (23)
20 (77)
.83
Test type
PNS
PND
39 (56)
30 (44)
22 (51)
21 (49)
17 (65)
9 (35)
.25
*2-sided Chi square tests performed.
Table 3. Demographic characteristics of women who made informed versus uninformed choices 
(N = 69).
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Informed choice outcomes
Figure 3 presents a pie chart of the outcomes of informed choice. Overall, 62.3% 
made a completely informed choice. A partly informed choice was made by 33.3% 
of women; 24.6% had poor knowledge, but a consistent attitude, and 8.7% had 
good knowledge, but an inconsistent attitude. Lastly, 4.3% made a completely 
uninformed choice.
For statistical analyses, level of informed choice was dichotomized in two lev-
els, informed and uninformed.
Relationship between decision outcome and demographic variables
There was a marginally significant association between educational level and in-
formed/uninformed choices (p = 0.055). Women who had a higher educational 
level tended to be more likely to make completely informed choices than women 
who had a lower educational level. There were no other statistically significant 
differences in demographic variables (see Table 3).
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Relationship between decision outcome and actual/hypothetical choices
As mentioned earlier, there was no significant association between informed/un-
informed choices and actual versus hypothetical choice. Thus, women choosing 
for pnS or pnd made equally informed choices.
Relationship between decision outcome and choosing broader or less 
broad testing
There was a significant association between informed/uninformed choices and 
choice of array resolution χ² (1) = 19.29, p < 0.001, V = 0.71 (large effect size), 
or = 0.36 (95% ci 0.17 — 0.79). Women who made a completely informed choice, 
opted for broader testing more often.
Relationship between decision outcome and disclosure of SL
There was no significant association between wanting to be informed about Sl 
and informed/uninformed choices. Thus, women opting for or against disclo-
sure of Sl made equally informed choices. There were no significant effects of 
wanting to be informed of Sl on either anxiety or doubts.
Figure 3. Piechart of decision outcomes of all women (N = 69).
8,7%
24,6%
4,3%
62,3%
Level of informed choice
Poor knowledge, 
consistent attitude 
Good knowledge, 
inconsistent attitude 
Adequately informed
Uninformed
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Anxiety & doubts and decision outcome
There were no significant differences in anxiety level (Stai) and informed versus 
uninformed choices. There was no significant difference in levels of doubts (daS) 
and informed versus uninformed choices. Thus, there were no differences in lev-
el of anxiety and doubts between women making informed versus uninformed 
choices. Mean anxiety and doubt scores for all women are displayed in Table 4.
There was a significant difference in anxiety (Stai) for women opting for pnS 
versus pnd. Women who opted for pnd, had a higher level of anxiety. There was 
no significant difference in level of doubt for women opting for pnS versus pnd 
(see Table 5). There were no differences in anxiety and doubts between women 
opting for or against disclosure of susceptibility loci (see Table 6).
Overall the anxiety and doubt scores decreased significantly between t1 and 
t2 (see Table 7). There were no significant differences in the course of anxiety 
and doubts between informed and uninformed decision-makers or between the 
pnd and pnS subgroups.
Informed choice Uninformed choice t p
n = 37; 51% n = 32; 58%
Mean STAI score 34.05 34.95 n.s.
Mean DAS score 25.11 25.81 n.s.
PND PNS t p
n = 29 n = 40
Mean STAI score 37.20 33.75 6.802 .012
Mean DAS score 22.90 26.86 n.s.
Table 4. Mean anxiety (Stai) and doubts (daS) score by decision outcome for all women (N = 69).
Table 5. Mean anxiety (Stai) and doubts (daS) score of women opting for pnd/pnS (N = 69).
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Discussion
The aim of the current study was to assess whether pregnant women had suffi-
cient knowledge to make an informed decision regarding the scope of their in-
vasive prenatal genetic test using Snp microarray that was consistent with their 
attitude. Furthermore, we explored whether level of informed choice was associ-
ated with anxiety and doubts.
Informed choice implies making a value-consistent decision based on suffi-
cient knowledge. Although the majority of women made a ‘completely informed’ 
choice (sufficient knowledge and consistent attitude), a substantial subgroup 
made a choice that was at odds with their personal values. Michie et al. (2002) 
showed that knowledge plays no role in whether women undergo screening or 
whether they act in line with their attitudes. Our study supports this finding; 
women who did not have sufficient knowledge were able to make a choice that 
was consistent with their attitudes, and vice versa. A small percentage of women 
with sufficient knowledge were still choosing value-inconsistently.
T0 T1 t p
n = 69 n = 69
Mean STAI score 35.03 26.82 5.390 <.001
Mean DAS score 28.86 18.32 5.135 <.001
+SL −SL t
n = 39 n = 23
Mean STAI score 36.49 32.22 n.s.
Mean DAS score 22.73 24.10 n.s.
Table 7. Mean anxiety (Stai) and doubts (daS) score of women after counselling (t0) and 4 weeks 
after disclosure of prenatal test results (t1) (N = 69).
Table 6. Mean anxiety (Stai) and doubts (daS) score of women opting for or against disclosure of Sl 
(N = 62).
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Anxiety and doubts were not higher in women who made an uninformed 
choice. These findings are in contrast to previous studies showing that making 
uninformed choices is associated with adverse psychological outcomes. Women 
who made uninformed choices had more decisional conflicts/doubts and felt 
more anxious when making a choice whether or not to engage in prenatal screen-
ing.12, 24 Therefore, we would have expected that making an uninformed choice 
(lack of knowledge) might bring more worries about choosing the right test, and 
that these worries may lead to more anxiety or stress. Alternatively, it is pos-
sible that the women who made an uninformed choice were not able to grasp 
the potential detrimental consequences of their choice. A lack of knowledge 
may only be stressful if one is aware of what is lacking. The percentage of in-
formed choices are concordant with other studies on informed choice in prenatal 
screening, although those studies used less stringent criteria, such as the mid-
point score.23, 25, 26
The concepts of adequately informed and uninformed choices are evident. 
However, partly informed choices lie in a more ‘grey area,’ which needs to be 
reflected upon. We found that most women who made partly informed choic-
es based their choice on insufficient knowledge but with a consistent attitude. It 
could be argued that partly informed choices can still be considered autonomous 
choices: women may not need the complete detailed facts and specifications 
about the test characteristics to make a choice that is in line with their values 
(or an expression of self-determination). In line with this, it may be argued that 
reproduction/recall of knowledge after counselling is less of a condition for au-
tonomous choice than agreement with one’s personal values.
Choices based on sufficient knowledge, but with an inconsistent attitude, 
were less prevalent. In line with an earlier study, our results show that knowl-
edge indeed played no role in whether or not the women acted in accordance 
with their attitudes (Michie et al., 2003). We argue that value-inconsistent choic-
es might be the most worrisome type of decision. If a woman chooses a scope of 
testing that does not fit her personal values, despite having sufficient knowledge 
about the test characteristics, this might lead to adverse psychological outcomes. 
It has to be taken into account that subtle signs of attitude inconsistency are easi-
ly missed. The counsellors’ preferences may have (inadvertently) influenced the 
pregnant women’s decision-making, leading women to make choices that were 
inconsistent with their own values despite enough knowledge.
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Actual versus hypothetical choices
No differences were found in the level of informed choice between the pnS and 
pnd groups. This might indicate that women who made a hypothetical choice, 
have gone through a similar decision (making) process as women who underwent 
pnd. However, there is a difference between the women engaging in pnS and 
pnd: women engaging in pnd made a real choice that was actually performed 
by our lab, and thus had higher stakes than women making a hypothetical choice 
(pnS). Our results show that women opting for pnd indeed experienced more 
anxiety than women engaging in pnS. It might be that level of anxiety is associ-
ated with informational needs. Alternatively, it could be that women engaging in 
pnd are more anxious because of the miscarriage risk associated with the inva-
sive procedure27. It must be noted that in our sample 19% of the pregnant women 
experienced anxiety at clinically relevant levels, and these women were distrib-
uted equally across the pnS/pnd groups. At follow-up, four weeks later and after 
they received test results, almost all anxiety scores were back to normal levels,22 
except for three women who experienced enduring anxiety.
Broad or less broad microarray and susceptibility loci
Women who opted for broad scope pnd made informed choices significantly 
more often. Being fully aware of the possible outcomes, they preferred to gain in-
formation about susceptibility loci in their unborn child. This might be related to 
the ‘sense of personal ownership’ of genomic data.28 Patients may be inclined to 
want ownership and/or control over their — or in this case their baby’s — genomic 
data. This may contribute to choosing a maximum of information from a genom-
ic test, even if that means the test would include uncertain outcomes such as sus-
ceptibility loci.21 Our first impressions were that women in our clinic appeared 
to be able to handle this kind of information. Moreover, women indicated that 
they could use this kind of information in the future, if their child would develop 
abnormally. They indicated that they would know where to start looking for help 
and/or mobilize adequate care.
The majority of well-informed women chose to be informed of susceptibility 
loci if detected. The finding that the majority of women make informed deci-
sions about susceptibility loci might seems in contrast with the often expressed 
fear/concern among professionals that these results are too difficult to grasp for 
patients.2, 29 However, the two positions are not mutually exclusive. Women may 
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be able to make an informed decision at the time, but not able to fully grasp/un-
derstand the long-term consequences of a rather abstract test outcome. On the 
other hand, professionals might underestimate the resiliency of their patients. 
We found that the women in our study did not have a heightened level of anxiety 
compared to other Dutch pregnant women at high risk of an abnormal fetus.22 
This finding is also incongruent with professionals’ worries of burdening preg-
nant women with an overload of information.2, 6, 11, 29
In conclusion, despite all of the controversy regarding prenatal micro arrays, 
our study shows that the majority of women were capable of making an informed 
choice regarding the scope of their invasive prenatal genetic test. And most im-
portantly, they made informed choices in the absence of severe anxiety or doubts. 
Our data have shown that overall levels of anxiety and doubts decreased signifi-
cantly over time, regardless of the choices (broad, less broad, Sl or no Sl) or level 
of informed decision-making. This decreasing pattern of anxiety is in accord-
ance with previous studies.22
It should be noted that choice/consent cannot and need not be completely 
informed.30 People may differ with regard to their informational needs and the 
level of detail they require for decision-making.31 For some, knowing that test-
ing may generate ‘information about severe, incurable conditions’ may be suf-
ficient, whereas others may need to know what conditions exactly are included 
in the test, in order to make an informed decision. To accommodate differences 
in informational needs among individual women, pre-test counselling can be 
conducted in a layered fashion, where basic, crucial information is offered to all 
women, and further, more detailed information is given if needed or desired.32 
The level of knowledge required for informed choice, it can be argued, may thus 
vary among individual decision-makers. Attitude consistency, on the other hand, 
is less of a spectrum, but rather a necessary condition for informed choice.
In the literature, efforts aimed at improving informed choices mostly target 
the knowledge component.17, 25, 33 We stress the importance of attitude con-
sistency, and recommend that the choices of pregnant women regarding the 
scope of their genetic test should fit their personal values well in order to facili-
tate informed choice. Thus, interventions aimed at improving informed choices 
through attitude consistency may be more effective than those targeting knowl-
edge only.12, 23 We suggest that attitude and values need to be explored and dis-
cussed in the pre-test counselling sessions.
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The telephone counselling enabled the majority of women to make an in-
formed choice. It must be taken into account, however, that this counselling was 
extensive and time-consuming, and therefore will not be feasible in everyday 
practice. It would be interesting to compare the level of informed choices with 
telephonic versus routine face-to-face counselling. Face-to-face counselling has 
a more personal aspect, and therefore might be capable of more adequately ad-
dressing attitude inconsistency or miscomprehension.
The future: the expansion of prenatal genetic information
Prenatal screening and follow-up diagnostic testing are likely to expand in the fu-
ture, and to become more complex, as more and more findings/conditions could 
be included in the test. This might not only be possible with invasive testing, but 
also with non-invasive prenatal test (nipt). Some state that in order to keep in-
formed consent feasible, unnecessary complications should be avoided: screen-
ing should only be used for trisomies 13, 18 and 21. However, complications may 
not always be unnecessary: tests may come to include other conditions that are 
as relevant to women or couples in reproductive decision-making as is Down syn-
drome. Multiple studies have shown that a majority of pregnant women prefer 
an individualized choice, and prefer to learn as much as possible from prenatal 
tests.2, 21, 34 Broadening the scope of prenatal diagnosis should — at minimum — 
be considered. To facilitate informed choices, pre-test counselling remains of 
great importance. Since extensive face-to-face counselling might not always be 
feasible, the next step may be to develop decision-aids that comprise both knowl-
edge and attitude and personal values. This could be especially helpful for wom-
en who may otherwise make choices that are inconsistent with their attitudes. 
Such solutions and new models of informed consent are more and more widely 
applied in healthcare systems, and they may indeed have the potential to im-
prove complex decision-making regarding the prenatal screening and follow-up 
diagnostic testing offer.35
Strengths & limitations
It should be noted that the women who present at the prenatal clinic of our uni-
versity medical center are of above-average educational level. Furthermore, 
participating women were already motivated to seek prenatal screening or diag-
nosis (on the basis of either advanced maternal age or abnormal first trimester 
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screening), and may thus be more inclined to prefer to learn about genetic risks 
in their fetuses than other pregnant women. Our results might be further biased 
due to the unequal distribution of ethnicity; only 7% of the women was not Dutch.
A strength of this study is that, to our knowledge, we are the first to have as-
sessed informed choice regarding invasive pnd performed with microarrays. 
Further, we allowed participants to make an individualized choice of array reso-
lution that best suited their preferences.
Conclusion
We found that the majority of pregnant women were capable of making an ad-
equately informed choice about the scope of invasive pnd, including whether 
or not they wanted to be informed of Sl. A justified course of action based on 
this result could be that laboratories perform broad analysis and counsellors pro-
vides patients with an opting in or out possibility. Knowledge has already been 
established as an important component in informed choice. However, our study 
underlines that a consistent attitude might be equally important. We anticipate 
that in the future, regardless of more complex or new techniques, the majority 
of women will still be able to make informed choices, as long as adequate in-
formation provision and counselling are provided. For counselling practices, 
we advocate a stronger focus on attitude-consistency instead of only a focus on 
knowledge.
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Abstract
Genomic microarray may detect susceptibility loci (Sl) for neurodevelopmental 
disorders such as autism and epilepsy, with a yet unquantifiable risk for the fe-
tus. The prenatal disclosure of susceptibility loci is a topic of much debate. Many 
health care professionals fear that reporting susceptibility loci may put a psycho-
logical burden on pregnant couples. It is our policy to disclose prenatal suscep-
tibility loci as we recognize them as actionable for prospective parents. The aim 
of this report was to evaluate the psychological impact of disclosing a prenatal 
diagnosis of susceptibility loci.
The psychological impact of disclosing susceptibility loci was evaluated in the 
first patients who received such results. Eight out of 15 women who had a suscep-
tibility locus disclosed and four of their partners consented to share their experi-
ences through a telephonic evaluation (n = 12). Follow-up time ranged from 3 to 15 
months after their prenatal test result.
The reporting of susceptibility loci was initially ‘shocking’ for five parents 
while the other seven felt ‘worried’. Ten out of 12 participants indicated they 
would like to be informed about the susceptibility locus again, two were unsure. 
Most had no enduring worries. Participants unanimously indicated that pregnant 
couples should have an individualized pre-test choice about susceptibility loci 
(non)disclosure.
We observed no negative psychological impact with the prenatal diagnosis 
and disclosure of Sl on participants. A key factor in mitigating parental anxiety 
with Sl disclosure appears to be post-test genetic counselling. Our report con-
firms that pregnant women and their partners prefer an individualized choice 
regarding the scope of prenatal testing.
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Introduction
Genomic microarray may detect more copy number variants (cnVs) that cause 
clinically relevant abnormalities and generates results faster than conventional 
karyotyping (cK).1–3 Therefore, we use Snp array instead of conventional karyo-
typing (cK) for routine cytogenetic analysis for all indications since July 2012.4, 5 
Next to known microdeletion syndromes such as Prader-Willi syndrome, or 
Duchenne muscular dystrophy, array testing may also reveal susceptibility loci 
(Sl) for neurodevelopmental disorders. Susceptibility loci (Sl) were defined as 
following by Girirajan et al.: ‘Sl are copy number variants (cnVs) with an extreme 
phenotypic heterogeneity and/or of variable expressivity’6–8 associated with an 
unquantifiable risk of neurodevelopmental disorders such as epilepsy, autism 
and psychiatric disorders and can be found in about 1.4% of fetuses without 
ultrasound anomalies.9, 10 Sl are often inherited from (apparently) unaffected 
parents, but are more frequently detected in affected individuals as compared to 
control populations.8, 11–13 Genetic counselling in pregnancies where Sl is found 
is challenging as it is difficult to estimate the chance of expression and/or to pre-
dict the phenotype because most likely a second hit like another genetic or even 
non-genetic factor, like environment, may also influence the expression of the 
phenotypes.14, 15 Almost all information about Sl phenotypes and penetrance 
that is available is based on postnatal ascertainment. There is currently no in-
formation available about the development of children in whom a Sl was found 
prenatally.
The value of Snp array in fetuses who were prenatally diagnosed with ultra-
sound anomalies has been widely accepted,2, 3 but its implementation for other 
indications has raised concerns among health care professionals, causing much 
debate regarding the disclosure of Sl.16–18 Some classify these cnVs as variants of 
unknown clinical significance (VouS),2 but because of their association with an 
abnormal phenotype, we have classified Sl as pathogenic.8 In our opinion, Sl are 
different from VouS because the phenotypic effect of VouS is unknown, whereas 
for an Sl the association with a specific phenotype is known but has a highly var-
iable penetrance and expression.
It has been argued that pregnant couples may wish not to be informed on 
findings of uncertain expression19 and that such findings should be withheld in 
order not to put burden on the pregnant couple.20, 21 It has also been said, both 
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for susceptibility loci and VouS, that reporting them may create a false sense of 
autonomy,22 because an overload of information could deteriorate reproductive 
autonomy, or raise possible emotional harm such as distress.23 Some ethicists 
argued that genetic information of unclear meaning interferes with reproductive 
autonomy and should not be provided for this reason.21
On the other hand, others argue that it is paternalistic to try to prevent women 
from emotional harm and potential termination of a pregnancy, and that preg-
nant women are entitled to be informed of all genetic information23 and that bet-
ter tools for dealing with uncertainty should be developed.20, 24–26
Although we are well aware of the burden that Sl may represent psycholog-
ically for the pregnant couple, for several reasons we have chosen to disclose Sl 
when prenatally detected. Firstly, we consider most Sl to be actionable during 
and/or after pregnancy. For example, Sl may be associated with congenital heart 
disease and an expert ultrasound examination during pregnancy can be offered. 
Secondly, if neurodevelopmental problems occur (either early or late onset), rap-
id diagnostics and more adequate care may be mobilized when parents have the 
knowledge of the Sl (Govaerts et al., manuscript in preparation).27
Since we implemented Snp array for all indications, we encountered 14 cases 
of Sl in 1330 pregnancies without ultrasound abnormalities.5 To date, no patient 
experiences regarding the psychological impact of Sl on pregnant couples has 
been reported. To explore whether disclosure of Sl indeed puts a heavy burden 
on the parents,20–23 we feel it is important to understand how Sl disclosure af-
fects pregnant couples. We report on the narratives of 12 parents’ experiences 
with a prenatally disclosed Sl.
Materials and methods
Pre-test counselling by a senior obstetrician
All patients undergoing invasive prenatal diagnosis (pnd) received pre-test coun-
selling by a senior obstetrician and received a patient information leaflet which 
specified that ‘all pathogenic results will be reported’. Pregnant couples were 
informed about array testing. The occasional occurrence of unexpected find-
ings was discussed. These could either be pathogenic cnVs not related to the 
prior indication for invasive testing or susceptibility loci (Sl), Patients received 
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no detailed information regarding Sl. Unexpected findings were discussed, but 
there was no strong emphasis on Sl as a category of outcomes of invasive prena-
tal testing. Snp array testing was performed as a first-tier diagnostic test as de-
scribed before.4, 9
Disclosing the prenatal test result
When a Sl was diagnosed pregnant couples were contacted directly by a clinical 
geneticist informing them that there was no causative chromosomal abnormality 
found, but a deviant finding that may require special attention. They were invited 
for extensive post-test counselling available the next day. For extensive informa-
tion about our counselling methods and pregnancy management, see Govaerts 
et al. (manuscript in preparation), in short:
1. The nature of the particular Sl was explained. Phenotypic examples (includ-
ing pictures) from the postnatal literature were available.
2. An expert ultrasound examination was offered if the Sl was associated with 
structural abnormalities.
3. We offered targeted parental Snp array in all cases because knowing whether 
an Sl was inherited aided in evaluating the clinical implications of the Sl 
within the family.
4. The couples were informed about the possibility for early postnatal interven-
tion programs (www.mee.nl), and the option to terminate the pregnancy was 
discussed.
5. The pregnant women and their partners were offered support from a medi-
cal psychologist specialized in prenatal care.
Inclusion for the psychological evaluation
In this report we describe the experiences pregnant couples had when a suscepti-
bility locus was found after invasive genetic testing, in the absence of ultrasound 
anomalies. Between July 2012 and
December 2013, fourteen couples received a prenatal diagnosis of a Sl, and 
all of them were contacted. A clinical geneticist informed on their situation and 
asked them whether they were willing to share their experiences by phone in 
order to assess the impact of disclosing a prenatal susceptibility locus. This in-
terview was part of aftercare in order to learn about the long term psychological 
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impact of Sl disclosure in pregnancy. All patients proceeding with invasive pre-
natal testing, signed consent for further follow up during pregnancy and after de-
livery. Eight women and four of their partners agreed to share their experiences, 
see Figure 1 for the participants. The prenatal testing indication and array find-
ings in 8 fetuses of the parents that took part in the interview are shown in Table 1. 
None of the participants decided to terminate the pregnancy. The parents of live 
born children reported no congenital anomalies or dysmorphic features that 
were detected at birth. In Table 2, array results are displayed with phenotype and 
incidences based on the information the parents received. All couples were of-
fered psychological support in dealing with the outcome after disclosure of Sl, 
but none of them indicated they wanted to make use of this.
The follow-up interview period between invasive pnd and the contact ranged 
between three and eighteen months. The mean time before the follow-up inter-
view was 10 months after disclosure. Three participants were still pregnant at the 
time of follow-up.
Measures
Consenting participants were approached for a follow-up interview by phone, 
using semi-structured questions (mean duration: 30 minutes). Women and their 
partners were interviewed individually. In Table 3, all questions are summarized. 
All interviews were transcribed verbatim and translated from Dutch to English. 
Worries about the health and development of the child were measured on a scale 
of 1 to 10 (1 — not at all to 10 — very much so).
Analysis
Qualitative analysis was performed on the answers of all participants. A pos-
teriori, three independent judges (Sl; JV; Sr) categorized the answers to the 
open-ended questions (see Table 4). Subsequently, the judges came to a consen-
sus regarding which categories emerged from which questions. The three judges 
independently assigned a dichotomous score (0 not present; 1 present) to each 
theme per question.
The observed inter-judge agreement varied between α = .44 and α = 1.00. The 
inter-judge reliability ranged from acceptable to excellent, except for question 1, 
which had a poor inter-judge reliability (α = .44).28
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14 couples with SL approached
8 participating women + 4 participating men
4 couples unreachable
4 couples participated
2 couples refused participation
4 women participated without partner
Figure 1. Flowchart of participants.
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Results: participant’s narratives
Initial experience when the SL was disclosed
Qualitative analysis of the interviews showed that 7 out of 12 participants said 
they were ‘worried’, while the other 5 participants said ‘it was real shock’ to hear 
about the Sl. We provide quotes to the answers by category. Participants marked 
with an asterisk (*) were still pregnant during follow-up.
Question 1 and 2
What was it like for you when you were told about the Sl that was found? What 
was your first reaction?
Quotes of parents who were worried (7 out of 12)
‘It startled me, you just don’t want to hear that about your baby. But I thought 
that our baby would develop normally, maybe a bit slower than others, but 
healthy in the end.’ (Participant 2, female)
‘It was unpleasant, because we thought everything would be fine. Thus far, it 
appears as such.’ (Participant 4, male)
1. What was it like for you when you were told about the Sl that was found?
2. What was your first reaction?
3. How do you feel about the Sl at this very moment?
4. Would you choose to be informed of Sl again?
5. Do you think that pregnant women should have a choice regarding the disclosure of Sl?
6. Please indicate on a scale of 1 to 10 how worried you are about the health/development of 
your child? (1: not worried at all, 10: very worried)
Table 3. Open-ended questions about the psychological impact of prenatal Sl disclosure.
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‘We were a little shocked at first, but we understood that there was only a very 
small chance that something could really be wrong. So we were not too worried.’ 
(Participant 6, male)
‘We were a bit upset the first days. When we had an advanced ultrasound, 
everything looked normal, that was a relief to us.’ (Participant 8, male)
‘It came very unexpectedly, I was a little overwhelmed, but I wasn’t really, really 
alarmed.’ (Participant 10*, female)
‘At first we were not too alarmed, because the baby did not have Down syn-
drome. But we felt the Sl diagnosis was slightly worrisome, because we did not 
know what we could expect at all.’ (Participant 11, male)
‘I was upset, because they could not tell me exactly how high the risk of devel-
oping the clinical features was. I just sat there stared at the geneticist and asked 
what it was, and if it was dangerous.’ (Participant 12, female)
Quotes of parents who were shocked (5 out of 12)
‘To us, it was very unclear at first. We heard something was wrong and it came 
as a shock, I was nervous. When we had an appointment with the geneticist to 
talk about it, we understood that the risk was quite low. I thought; ‘we’ll have 
to wait and see’, but my husband was really worried. There was a picture of a 
patient with the same deletion, clearly showing something was wrong. This was 
very upsetting to us. We didn’t really know what to do with the provided infor-
mation. I wasn’t expecting it and did not think about the possibility of this kind 
of outcome when we engaged in prenatal diagnosis, only about the possibility 
of a trisomy. Maybe our older daughter has this deletion too, but she is a healthy, 
normal girl.’ (Participant 1, female)
‘That was a real shock. It was quite upsetting. We thought; What is going to hap-
pen next? It was not a very nice time. ’ (Participant 3, female)
82
chapter 4
‘We were startled, it was quite something. But we were informed of the possibili-
ty of such results.’ (Participant 5, female)
‘Unpleasant. It came as a shock. We did an amniocentesis hoping to hear that 
everything is alright, and then this susceptibility locus came as a test result. 
I was very emotional.’ (Participant 7*, female)
‘That was a real shock. It was not clear what was wrong, that made me worry a 
lot. The more I thought about it, the more worried I became. I had a lot of ques-
tions. I kind of panicked. Luckily, we had an appointment with the geneticist the 
next day. After that, I felt calmer.’ (Participant 9*, female)
Question 3
How do you feel about the Sl at this very moment?
Quotes of parents that do not think about it often anymore (11 out of 12)
‘I don’t think about it too much now.’ (Participant 2, female)
‘I don’t think about it anymore. I think I just have a normal, healthy son.’ 
(Participant 3, female)
‘I don’t look back on it. I gave birth to a healthy son.’ (Participant 4, female)
‘I like to think that nothing is wrong. At the moment, I don’t see any reason to 
think there is.’ (Participant 5, male)
‘During pregnancy I was worried about other physical abnormalities. But now 
that I gave birth, I am not worried anymore.’ (Participant 5, female)
‘I don’t think about the Sl anymore. I think I coped with the information quite 
well.’ (Participant 6, male)
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‘Most abnormalities were excluded with expert ultrasound examinations. We 
are only unsure of other neurodevelopmental symptoms like behavioural prob-
lems. But we think everything will be fine.’ (Participant 7*, female)
‘After the expert ultrasound examinations we felt reassured. The Sl does not 
have to mean anything.’ (Participant 8, male)
‘I think the chance of expression of the Sl is very small. And if it will express 
itself, I think it will be mild and actionable.‘ (Participant 9*, female)
‘We will have to wait and see. I think it is nothing very severe, since I carry it my-
self and do not have any symptoms. I am not too worried anymore.’ (Participant 
10*, female)
‘I think it might be something very mild. My wife has it too. Maybe we will not 
even notice it.’ (Participant 11, male)
‘I do not see anything out of the ordinary regarding my daughter at this point.’ 
(Participant 12, female)
Quote of a parent that experienced a stigma (1 out of 12)
‘It is something that you keep carrying with you. If she behaves weirdly, then 
I immediately think that this behaviour is related to the Sl. I also do not 
like the fact that she already had a medical file before she even was born.‘ 
(Participant 1, female)
Question 4
Would you choose to be informed of Sl again?
Yes (10 out of 12 parents)
‘I want to know as much as possible. That is the reason I chose for invasive pre-
natal diagnosis in the first place.’ (Participant 2, female)
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‘Yes, even though it was distressful when we first heard about the susceptibility 
locus. But if something might be wrong with your child, you want to know about 
it.’ (Participant 4, male)
‘If I could choose, than I would like to know.’ (Participant 6, male)
‘Absolutely.’ (Participant 8, male)
‘Yes, I think so, because I prefer to know as much as possible.’ 
(Participant 10*, female)
‘Personally, I want to know everything, but I have an academic degree. I can 
imagine that this kind of information might be very confusing for people with a 
lower educational level.’ (Participant 11, male)
‘Of course. Especially with regards to my advanced maternal age.’ 
(Participant 12, female)
Hesitant (2 out of 12 parents)
‘If I would get pregnant again, I might not want to know. But in this pregnancy, 
I would not want to have missed this information.’ (Participant 1, female)
‘It depends if it really matters. It did give us a lot of stress, because we thought 
it was something very severe at first. But I would be very curious in the future 
(next pregnancy). A friend of mine, who had children at a young age, did not 
have any genetic information about her children at all. But her son has a neuro-
developmental disorder and she did not know about it in advance. It can be use-
ful, because you know where it might come from.‘ (Participant 9*, female)
Worries about the health and development of the child ranged from 2 to 7 on a 
10-point scale (see Table 4). Most participants mentioned that they now ‘just 
have the normal worries any parent has’.
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Discussion
Since it has been suggested that disclosure of Sl may raise emotional harm, we 
evaluated the psychological impact of prenatal Sl disclosure on pregnant couples. 
Women and their partners initially felt worried and shocked. Most parents indi-
cated that the Sl was not what they had expected from invasive pnd, however 
some recalled being informed on such possibility during the pre-test counselling. 
Previous research showed that pregnant women are hardly ever ready for receiv-
ing abnormal prenatal test results, even if they are well informed.36–38
After their initial reaction, parents were confused and had a high need for un-
derstanding these outcomes. Most were quite alarmed by the phone call of the 
geneticist telling them that there was a ‘peculiar finding that needed explana-
tion’. All parents indicated they appreciated that the post-test counselling was 
available the next day. Due to the highly variable penetrance and expression, the 
meaning of the particular finding remained uncertain for the parents. A few par-
ents noted that this uncertainty was stressful to them at first. However, none of 
the parents made use of the psychological support they were offered. None of 
the participants felt that a termination of pregnancy was a personal option for 
them. The interviews revealed that some parents adopted a wait-and-see policy; 
that they will have to wait and see in which way their child will develop, with a 
positive state of mind. These parents seemed less distressed when talking about 
their experiences.
Parents seemed to have recovered from their initial feelings, and are now 
handling the knowledge about their child having a Sl fairly well. They seem to 
base this on a seemingly normal phenotype, either after giving birth to a ‘nor-
mal appearing’ child or with the reassurance of a ‘normal’ expert fetal ultrasound 
examination. At the moment of the follow-up interview (mean time 10 months 
after disclosure), all born children had no congenital anomalies or dysmorphic 
features, but were still too young to be examined for neurological development. 
None of the fetuses had ultrasound anomalies. It is yet unknown whether these 
children will develop neurodevelopmental symptoms in the future. Most par-
ents did not have lingering worries regarding the Sl, except for one woman who 
experienced a stigma regarding her seemingly normal and healthy born daugh-
ter. She told that each time her daughter behaved aberrant, she immediately 
feared it might be caused by the Sl. This is something that is also encountered 
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in other studies on abnormal prenatal diagnoses, even if the child has seemingly 
normal appearance.36 Other parents did not report stigma or enduring worries 
about the child’s development, and mentioned they just have ‘normal parental 
worries’ now. The interviewed parents indicated feeling relieved after advanced 
ultrasound scanning revealed no visible anomalies. We also found that parents, 
identified as Sl carriers themselves, were in a way relieved, because they had the 
feeling the child could be ‘normal’ like themselves. These parents used them-
selves or their partner as a reference for the interpretation of the Sl in their fe-
tus. The psychological reaction reported by the individuals in our clinic may have 
been milder as compared to the study of Bernhardt et al. (2013). In that study, 
23 participants were interviewed after disclosure of abnormal prenatal microar-
ray results, of which 9 were known pathogenic results and 14 were variants of 
unknown clinical significance (VouS). As in our study Bernhardt observed that 
participants initially felt shocked and worried, and had a problem with under-
standing the uncertainty and unquantifiable risks. Participants also shared a 
high need for support to manage and understand their prenatal microarray re-
sults with the help of a health care professional. However, in our study all women 
and their partners were counselled by a senior geneticist, whereas in the study 
of Bernhardt such support was not offered in all cases which might explain to the 
enduring concerns and a lack of support to manage decisions about termination 
of pregnancy and/or birth.. In both Bernhardt’s study and our own, a key factor 
in mitigating parental anxiety with Sl disclosure appears to be post-test genetic 
counselling.36 However, in our study, participants reactions seem milder. In the 
study of Bernhardt, most participants indicated that they felt their test result was 
‘toxic knowledge’. In our study however, most participants indicated that they 
‘just have normal parental worries now’, which clearly is a different outcome. The 
fact that all but one woman would choose to be informed of prenatal Sl again, is 
a strong indicator of this.
Nearly all parents indicated they would want to be informed of Sl again if 
offered a choice. Parents who said they preferred to know about Sl, said they did 
so because they could quickly mobilise adequate care if needed. For instance, if 
developmental problems would occur, they could have access to early interven-
tions for i.e. autism. These findings are congruent with our earlier study in which 
we found that a vast majority of pregnant couples, when offered a choice during 
pretest genetic counselling, opted for Sl disclosure.39 The parents we discussed 
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in this study indicated that they would prefer to have a choice regarding the (non)
disclosure of Sl. This study supports earlier reports16, 39, 40 that parents highly 
appreciate individualized choice on the scope of prenatal testing. We have not 
observed psychological burden, however it has to be taken into account that the 
number of interviewed patients is small. Furthermore, some participants were 
still pregnant at the time of the interview. It is therefore difficult to make long-
term conclusions. In our study, there was no distinction between prenatal de 
novo and inherited findings, however, due to their different nature parents might 
cope with them in another way. It would be interesting to evaluate this. Research 
on a larger scale is much needed to gain more insight in how pregnant couples are 
coping with this type of prenatal information.
Conclusion
This small study showed that in our setting, there was no long-term psychologi-
cal burden for pregnant couples whose fetus was diagnosed with a susceptibility 
locus. A key factor in mitigating parental anxiety with Sl disclosure appears to 
be post-test genetic counselling. This study confirms that parents highly appre-
ciate an individualized choice on the scope of prenatal testing. We believe that 
if genomic microarray testing is offered, a chance of the detection of results like 
susceptibility loci should be routinely mentioned during pre-test counselling. An 
opt-out possibility may be sufficient to support the reproductive autonomy of 
pregnant couples.
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Abstract
Testing options for pregnant women at increased risk of common aneuploidies 
are non-invasive prenatal testing (nipt) and invasive prenatal diagnosis (pnd). 
Counsellors are challenged to comprehensively discuss the complex informa-
tion in a patient-centered and non-directive manner, to allow for patients’ in-
formed decision-making. This study explored the information-centeredness, 
patient-centeredness and level of non-directivity of different counsellors and 
examined group differences between their patients. First, semi-structured inter-
views with four senior obstetricians and one senior nurse were held regarding 
their information provision, their adaptation of a patient-centered attitude, and 
their practice of non-directivity. Interviews were transcribed verbatim and rated 
by four independent judges. Secondly, 181 pregnant women were included in the 
study, of whom 82% opted for nipt and 18% chose pnd. Between counsellors, we 
assessed the distribution of choice ratios, patients’ impression of counsellors’ test 
preferences, and patients’ knowledge scores. The results indicate that counsel-
lors do not differ in their level of information-centeredness, but do differ in their 
level of patient-centeredness and their level of non-directivity. Significant differ-
ences in patients’ nipt/pnd ratios were observed between counsellors, with the 
largest difference being 35% versus 4% opting for invasive pnd. Between 9% and 
22% of the patients had an impression of their counsellor’s preference and chose 
in accordance with this preference. Patients’ overall knowledge scores did not 
differ across counsellors. In conclusion, the differences in nipt/pnd ratios be-
tween counsellors indicate that counsellors’ differences affect the choices their 
patients make. The interviews indicate a possible framing effect which may un-
intentionally steer the decision-making process.
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Introduction
Because of recent developments in prenatal genetic testing, more testing op-
tions have become available for pregnant women. Women with an abnormal first 
trimester screening (FtS) result need to make important decisions about how 
they wish to proceed in their prenatal care. As of now, pregnant women in the 
Netherlands have three options as depicted in Figure 1: 
1. no further testing, 
2. invasive prenatal diagnosis (pnd), and 
3. non-invasive prenatal testing (nipt).
The primary goal of pre-test counselling is to enable the pregnant woman 
and her partner to make an informed choice and to give informed consent for ei-
ther nipt or invasive pnd, or refrain from further testing. The eventual decision 
should be based on relevant knowledge, consistent with the couple’s values, and 
behaviorally implemented.1 During pre-test counselling, information is provided 
about the benefits and limitations of both nipt and invasive pnd, as well as the 
potential to detect findings other than the indication for testing.
Besides informing pregnant women and their partners, the counsellor 
should address individual attributes of the patient, such as emotions and resil-
ience.2 A focus on patient-centeredness in prenatal counselling is expected to 
lead to more well-deliberated choices and less psychological distress for patients. 
Kessler3 has differentiated between the teaching model and the counselling 
model. Whereas the teaching model aims for educated patients, the counselling 
model aims for patients to feel understood, in control, and competent. These 
outcomes are desirable, but also require a much broader set of counselling skills. 
The counsellor should then not only inform, but should also elicit information 
from patients about their needs and use this information to guide the counselling 
session.3, 4
Genetic counselling traditionally implies a non-directive attitude. According 
to Kessler 5, non-directive counselling aims to facilitate patients to think about 
their considerations, which is different from directive counselling, aiming to pre-
scribe and influence the patients’ behavior. While directive counselling involves 
persuasive coercion, thereby targeting the decision outcome, non-directive 
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counselling promotes the patient’s autonomy and self-directedness, so that the 
decision-making process is optimized.3, 4
A recent Dutch study demonstrated that nationwide, about 3% of pregnant 
women with an increased FtS result chose invasive prenatal testing while about 
97% chose nipt.6 At the Erasmus Medical Center in the Netherlands, nearly 20% 
of the pregnant women opted for invasive pnd while around 80% chose nipt.7 
The difference in choice ratio may be explained by this center’s different poli-
cy regarding invasive prenatal testing. Whereas other academic centers in the 
Netherlands perform Quantitative Fluorescence-Polymerase Chain Reaction 
(QF-pcr) on fetal dna to examine chromosomes 13, 18 and 21, here, high reso-
lution Snp array at 0.5 Mb is performed to analyze all chromosomes at a submi-
croscopic level.8 This microarray provides much more detailed information on 
additional chromosomal aberrations.
The increasing scope of possible findings provided by Snp array and nipt 
may jeopardize sound prenatal genetic counselling.9 As the complexity of ge-
netic counselling increases, it may become demanding for pregnant women 
and their partners to understand the test characteristics and implications.10–12 
Subsequently, the informed decision-making process of pregnant women and 
their partners requires more extensive pre-test counselling.
The higher invasive pnd uptake rate at the Erasmus Medical Center compared 
to other academic centers, and the even more challenging task of counsellors to 
comprehensively discuss the different testing options and test outcomes of pnd 
with their patients, increases the need to explore the approach of the different 
counsellors in this center and the content of their prenatal genetic counselling. 
Therefore, we explored the information-centeredness, patient-centeredness and 
level of non-directivity of different counsellors by means of semi-structured in-
terviews. We used data analysis to compare the ratio of patients’ choices for either 
nipt or invasive pnd between counsellors and we examined whether patients 
had an impression of their counsellors’ preferences. Finally, we assessed whether 
there were group differences in patients’ knowledge scores between counsellors.
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Materials and methods
For this study, qualitative and quantitative data were collected. Qualitative data 
about counsellor characteristics were obtained by semi-structured interviews with 
prenatal genetic counsellors. Quantitative data about group differences between 
patients of different counsellors were obtained from previously collected data.7
Qualitative data
Counsellors working at the Erasmus University Medical Center in Rotterdam 
who provided counselling to more than 15 patients in an earlier study7 were eligi-
ble for the qualitative interview study (N = 5). All five counsellors had senior posi-
tions, with 15+ years of experience in the prenatal genetic testing field. One coun-
sellor was a senior nurse, the other four counsellors were senior gynecologists/
obstetricians. The senior obstetricians performed chorionic villus sampling and 
amniocentesis themselves, whereas the senior nurse did not. The age range of 
counsellors was 42–51 years. All counsellors were familiar with providing coun-
selling for invasive pnd, and when nipt was introduced in the Netherlands, they 
were formally trained in a Dutch national program about offering this choice 
alongside invasive pnd as part of the Trial by Dutch laboratories for Evaluation 
of Non-invasive Prenatal Testing (trident). The counsellors welcomed preg-
nant women who had an increased risk based on first trimester screening and 
who subsequently had to choose between no further testing, nipt, and invasive 
prenatal testing. In total, 181 pregnant women were counselled in this study. 
Counsellor one counselled 49 patients, counsellor two 71 patients, counsellor 
three 23 patients, counsellor four 15 patients, and counsellor five 23 patients. The 
interviews focused on three important themes of prenatal genetic counselling, 
as previously described in the introduction: 1) information-centeredness, 2) 
patient-centeredness, and 3) non-directivity.
First, the counsellors were asked how and to what extent they inform preg-
nant women and their partners about the choice between nipt and invasive pnd 
(information-centeredness), i.e. the different choice options, goals and methods 
of testing, test characteristics and limitations, risk-communication, turnaround 
time of results, and possible outcomes and implications. Veach et al. stated that 
‘presentation and discussion of relevant information allows patients to gain im-
proved understanding and develop a new or different perspective’.2 Second, it 
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was explored how and to what extent the counsellor addresses the pregnant 
women and their partners’ thoughts, feelings, values, family dynamics, and 
psycho social context and promotes emotional well-being by giving support, 
validation, and assistance with coping; patient-centeredness.2 The balance be-
tween patient-centeredness and information centeredness was discussed. Third, 
it was explored to what degree counsellors adopted the concept of non-direc-
tivity in their counselling. In the exploration of this concept, directiveness and 
non-directiveness were not used as categorical opposites, but rather as extremes 
on a continuum related to the level of patient autonomy.13 Counsellors elaborat-
ed on the existence and definition of non-directivity and on how this concept was 
implemented in their counselling. We asked counsellors whether at times they 
were inclined to provide directive advice about the best option for the patient and 
whether counsellors had a personal preference towards a specific test.
To illustrate counsellor characteristics scores, we have selected several quotes 
from each counsellor regarding his/her level of information-centeredness, 
patient-centeredness and non-directivity. Although these quotes are fragments 
of the answers counsellors gave during the interviews, we consider them to be 
archetypical of the counsellor’s approach.
Qualitative Analysis
The interviews were conducted in Dutch and transcribed verbatim. The tran-
scriptions of the interviews were scored by four independent judges (SS; dh; 
Sr; at). Using a five-point Likert scale, the judges each formed an individual 
evaluation of the counsellors’ level of information-centeredness (1 = very low 
to 5 = very high), patient-centeredness (1 = very low to 5 = very high), and the de-
gree of non-directivity (1 = fully directive, i.e. low patient autonomy to 5 = fully 
non-directive, i.e. high patient autonomy). Four judges rated the five counsellors 
on three categories, resulting in 15 ratings per judge. More than two points differ-
ence between judges’ ratings was regarded as substantial, and a consensus meet-
ing was held to discuss these differences. Subsequently, judges could adjust their 
individual scores, eliminating these substantial differences. After adjustment of 
the scores, for each counsellor, the mean score on each of the three concepts was 
calculated. Finally, for all 15 sets of four ratings we calculated both the percent-
age absolute agreement between judges and the percentage of ratings with not 
more than one point difference (on the five-point scale) between judges.
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Quantitative Data
Pregnant women and their partners who visited the outpatient clinic of prenatal 
medicine in the Erasmus mc, University Medical Center Rotterdam, between 
April 2014 and November 2015 were invited to participate in a study 7 measur-
ing informed choice for patients opting between nipt and invasive pnd. For the 
present study, we made use of the same data, however, we compared patients 
scores between counsellors instead of between test choice.
Inclusion criteria for the patients were: a) an elevated risk on common an-
euploidies based on first-trimester screening and b) engaging in either nipt or 
invasive pnd. Exclusion criteria were: 
1. a recurrence risk for trisomies based on earlier pregnancies or heredity, 
2. a fetal nuchal translucency >3.5 mm, and 
3. patients who were counselled in satellite hospitals in the South-West region 
of the Netherlands. One-hundred and eighty-one pregnant women were 
included in the study.
Consenting participants completed a questionnaire that assessed: 
1. their choice for either nipt or pnd, 
2. their impression of the counsellor’s preference, and 
3. their level of knowledge. 
Social demographic background, level of education, nationality, age, religios-
ity and obstetric history were collected. The ratios of patient’s choices for either 
nipt or invasive pnd between counsellors were computed. Whether the patients 
had an impression of the counsellor’s own preference for either nipt or invasive 
pnd was measured by one item (‘I feel like the choice I made had the doctor’s 
preference’), answered on a 10-point visual analogue scale. We were especially 
interested in the distribution of high scores per counsellor, indicating that the 
patient followed a clearly expressed preference of the counsellor. Therefore, we 
reported scores >8 on this item per counsellor. The Measure of Informed Choice 
(mic) was part of the questionnaire and previously designed to assess the lev-
el of informed decision-making after pre-test counselling.7 The mic consists of 
two scales; Knowledge (with a reliability of α = .55 [ref. 7]) and Attitude (with a 
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reliability of α = .78 [ref. 7]). The Knowledge scale has nine multiple-choice ques-
tions regarding the test capacities of nipt and invasive pnd.
Quantitative analysis
To analyse the data, the multiple-choice answers of the Measure of Informed 
Choice (mic) knowledge scale were dichotomized, where ‘0’ represented an in-
correct answer and ‘1’ a correct answer. Sufficient knowledge was determined to 
be seven (7/9 = 77.8%) or more correct answers on the mic Knowledge scale. We 
chose such a conservative criterion because we place great priority on thorough 
and extensive provision of information during counselling. Chi square tests were 
used to test differences in patients’ total knowledge scores between counsellors 
on the mic knowledge scale. To evaluate the differences on individual items of 
the mic between counsellors, McNemar tests were conducted. Paired samples 
t-tests were used to investigate the differences in total knowledge score of pa-
tients between counsellors. Chi square tests were used to test differences in the 
uptake ratio of nipt or pnd between counsellors and to test for differences in 
patient characteristics between counsellors. For all statistical tests, a significance 
level of α = .05 was used.
Results
Counsellor characteristics
The mean scores on the categories of level of information-centeredness, 
patient-centeredness and non-directivity per counsellor are displayed in 
Table 1. The average percentage of absolute agreement between judges was 
61.7% (Min = 50%, Max = 100%) and the percentage of ratings with not more 
than one point difference between judges was 83.3% (Min = 75%, Max = 100%). 
Counsellors do not differ in their level of information-centeredness, but do differ 
in their level of patient-centeredness and their level of non-directivity. Figure 2 
shows interview findings and quotes to illustrate and support the findings in this 
study.
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Counsellor
Information 
centeredness 
(scale 1–5)
Patient 
centeredness
(scale 1–5)
Level of
non-directivity
(scale 1–5)
1 4.3 4.5 4.5
2 4.5 3.8 3.0
3 4.0 4.0 2.8
4 3.3 2.5 3.5
5 4.0 3.8 5.0
Table 1. Counsellors and their individual characteristics* as derived from the semi-structured 
interviews. 
* Counsellor characteristics were derived as the mean rating based on scoring of the interviews by 
4 separate judges (SS; dh; Sr; at).
N % C1 C2 C3 C4 C5 p-value (x)
Educational level
Low/intermediate
High
59
122
33%
67%
41%
59%
28%
72%
17%
83%
27%
73%
48%
52%
.106
Nationality
Dutch
Other
167
14
92%
8%
94%
6%
89%
11%
96%
4%
87%
13%
100%
0%
.293
Religiosity
Religious
Non-religious
38
143
21%
79%
10%
90%
24%
76%
4%
96%
40%
60%
35%
65%
.007*
Previous children
Yes
No
101
80
56%
44%
71%
29%
57%
43%
57%
43%
67%
33%
17%
83%
.001*
Previous miscarriages
Yes
No
46
82
25%
45%
32%
68%
35%
65%
43%
57%
50%
50%
31%
69%
.793
Missing 53 29%
* = Significant (<.05)
Table 2. Demographic data of participating women (N = 181). 
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Information-centeredness
Counsellor 1 ‘I am talking a lot! You must give patients a lot of information. I start with the 
invasive test. It is a diagnostic test and NIPT gives a probability of trisomy 21, 
18 and 13. I ask them if they have heard about it. If they say yes, I do not go 
into a lot of detail about it. I ask them if they know what it is, and what they are 
going to do in case of an abnormal result.’
Counsellor 2 ‘I explain them there are three options; no further testing, NIPT or invasive 
PND and about the technical capacities of these tests. We are looking at all 
the chromosomes on a detailed level and it is possible to detect thousands of other 
aberrations that might be equally relevant, and that the background risk is the 
same for everyone in the population.’
Counsellor 3 ‘I start with the FTS result. Then I ask if they know what chromosomes are. 
I explain that chromosomes are genetic building blocks, and sometimes there is 
a bit too much or too little of it. If that’s the case, then it might have conse-
quences for the fetus. To test the chromosomes you can opt for NIPT or PND. 
I weigh the patient’s specific FTS result to the risk of a miscarriage due to the in-
vasive procedure and the chance to detect something with NIPT. I also talk about 
the family composition, and the personal values of the women or couple.’
Counsellor 4 ‘I start with the increased FTS result and tell them that they can accept this risk 
and do nothing or proceed with NIPT/PND. I tell NIPT is not that reliable and 
only for trisomy 21, 18 and 13. About invasive PND I tell that we “just look at 
all the other chromosomes” as well. I do not go into detail about this. I also tell 
them that there is a very small risk of a miscarriage.’
Counsellor 5 ‘I tell them that NIPT, like FTS, is also a probabilistic test, no 100% certainty. 
Invasive PND does give certainty and is capable to detect more aberrations. I tell 
them that NIPT has no miscarriage risk and is designed to detected trisomy 
21, 18 and 13. I also explain the symptoms of these trisomies and what it might 
mean for the fetus.’
Figure 2a. Quotes to illustrate counsellors’ answers and their individual scores on characteristics. 
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Figure 2b. Quotes to illustrate counsellors’ answers and their individual scores on characteristics. 
Patient-centeredness
Counsellor 1 ‘I always start with; ‘How are you? Did the abnormal FTS result come as a 
shock? How are you feeling about the result now? Do you already know what 
your preference for testing is?’ If I don’t do this, then they are not open to my more 
technical information about NIPT/PND.’
Counsellor 2 ‘I always ask: Do you think it is important to have a definite result? Do you think 
it is important to have a fast result? How much tolerance for uncertainty do 
you have? Are you afraid of risks? What are you going to do with a normal/
abnormal test result? Have you thought about a termination of pregnancy? 
I am emphasizing they should make a choice that fits their personal values most.’
Counsellor 3 ‘My story is always more or less the same, with small variations; I explain 
what chromosomes are, how the invasive PND procedure works, what the 
miscarriage risk is, what the pros and cons of both NIPT and invasive PND 
are.’ ‘I ask about the family structure and living situation. How many previous 
kids? Do those have special needs? What are your resources?’
Counsellor 4 ‘It is not my job to explore which choice would be the best fit for the patient, 
right? It is up to the couple to decide which road they could best take.’
Counsellor 5 ‘I open my counselling with informing about how the woman is doing when she 
enters my room. I ask, “How are you? How do you feel about the abnormal 
FTS result? What are you going to do with the outcomes of a follow-up test (in the 
case of NIPT/PND)?” I try to ask them about the way their choice feels for them, 
whether it be NIPT, PND or no further testing.’
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Non-directivity
Counsellor 1 ‘Non-directive counselling. Completely neutral. I don’t know… I think I am 
trying my best to do that. But I have my own style and the way you communicate 
risks is of big influence on the patients’ perception of that risk. You always bring 
a piece of your personality into the counselling. I try to be as neutral as possi-
ble. I take the patient and her background and emotions into account.’
Counsellor 2 ‘I tell that with invasive PND, you test for more than just the common tri-
somies. I tell that NIPT is a good screening test, and invasive PND provides 
certainty. The additional risk of a miscarriage is nihilistic. I also talk about 
the expanded scope of invasive testing. The extra information PND yields is a 
bonus.’ ‘I believe in non-directivity, however, you cannot filter out things like 
non-verbal communication or unbalanced time distribution when explaining 
NIPT or invasive PND.’
Counsellor 3 ‘I do not give advice, I counsel people. They should make their own choice. 
I do confirm them in their choices, but I never try to ‘talk them into’ anything. 
Sometimes you need to decide together with the patient. It is important that 
people do not feel regret for their choices afterwards.’ ‘I think we should 
keep doing invasive tests and I am pro-invasive testing… oh, I am not only 
pro-invasive, I am also pro-NIPT by the way…’
Counsellor 4 ‘I think non-directivity is a great principle, but that it is hard to maintain it all of 
the time. But yes, I do think it is very desirable to counsel in a non-directive 
fashion. I try to counsel as non-directive as possible and to give the infor-
mation about it as clearly as I can. When they ask me for advice, I say that 
it is not my child and I am not the one who is pregnant, but I am willing to go 
through all information about the options again. I tell them the risk of a mis-
carriage is actually quite small, but when it happens, it is a great tragedy.’
Counsellor 5 ‘I think it is most important to explain people what both options comprise and 
what the consequences can be. I never ever give advice. I tell them that they have 
to make their own choices, even if they ask me what I would do.’ ‘I do say that 
in the experience of my patients, chorionic villus sampling is often perceived 
as a more unpleasant procedure.’
Figure 2c. Quotes to illustrate counsellors’ answers and their individual scores on characteristics. 
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Patients’ group differences
Demographics
The mean age of patients was 34.6 years. Between patients of different counsel-
lors, there were no significant differences in demographic variables, except for 
religiosity, and having previous children (as depicted in Table 2); 83% of patients 
from Counsellor 5 did not have previous children, while the other counsellors 
more often saw patients that did already have children, and 40% of the patients 
from Counsellor 4 were religious, versus 4% of the patients from Counsellor 3.
Counsellor 1 Counsellor 2 Counsellor 3 Counsellor 4 Counsellor 5
14
%
35
%
9
%
20
%
4
%
86
%
65
%
91
%
80
%
96
%
NIPT invasive PND
Figure 3. Ratio of patiens’ choices for nipt or invasive pnd between counsellors (N = 181)
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Choice ratios
Patients’ choices for either nipt or pnd differed significantly between counsel-
lors (χ² (4) = 11.98, p = 0.017). The largest difference was found between counsel-
lor 2 and counsellor 5, being 35% versus 4% opting for invasive pnd, as depicted 
in Figure 3.
Patients’ impression of counsellor preference
The mean and median scores of the question ‘I feel like the choice I made had the 
doctor’s preference’ are displayed between counsellors in Table 3. Table 3 also 
depicts the percentage of patients for each counsellor who indicated they had an 
impression of their counsellor’s preference. Between 9% and 22% of the patients 
had an indication of the counsellor’s preference and chose in accordance with 
this assumed preference.
Patients knowledge scores
Patients’ mean knowledge scores were high. Most pregnant women and their 
partners answered all questions correct and displayed good testing knowledge. 
Knowledge scores did not differ across counsellors. However, patients’ individu-
al item scores of either nipt or pnd questions differed significantly across coun-
sellors, as depicted in Table 4.
N Mean Median Frequency score ≥ 8 Percent score ≥ 8
Counsellor 1 49 3.68 4.50 6 12.0%
Counsellor 2 71 4.04 4.00 16 21.6%
Counsellor 3 23 3.00 2.00 3 13.0%
Counsellor 4 15 4.00 5.00 2 13.3%
Counsellor 5 23 2.65 1.00 2 8.7%
Table 3. Mean and median item scores between counsellors and percentage of patients (N = 181) 
who indicated they had an impression (≥ 8, range 0–10) of the counsellor’s preference and chose 
in accordance.
140
chapter 6
It
em
To
ta
l
N
 =
 18
1
C
1
N
 =
 4
9
C
2
N
 =
 71
C
3
N
 =
 2
3
C
4
N
 =
 15
C
5
N
 =
 2
3
1.
 
W
hi
ch
 m
at
er
ia
l i
s u
se
d 
fo
r n
ip
t 
te
st
in
g?
.9
9
1.0
0
1.0
0
1.0
0
1.0
0
1.0
0
2.
 
W
hi
ch
 a
be
rr
at
io
ns
 d
oe
s t
he
 n
ip
t 
de
te
ct
?
.9
9
1.0
0
.9
6
1.0
0
1.0
0
1.0
0
3.
 
W
ha
t i
s d
on
e 
to
 v
er
ify
 a
n 
ab
no
rm
al
 n
ip
t 
re
su
lt?
.9
6
1.0
0
.9
4
1.0
0
.8
0*
.9
3
4.
 
W
ha
t i
s t
he
 m
is
ca
rr
ia
ge
 ri
sk
 o
f t
he
 n
ip
t?
.9
8
1.0
0
.9
8
1.0
0
.9
0
1.0
0
5.
 
Af
te
r h
ow
 m
an
y 
w
ee
ks
 o
f g
es
ta
tio
n 
ca
n 
ni
pt
 b
e 
pe
rf
or
m
ed
?
.9
5
.9
5
.9
6
1.0
0
.9
0
.8
6
6.
 
W
ha
t i
s t
he
 re
lia
bi
lit
y 
of
 th
e 
ni
pt
?
.8
5
.9
5
.6
4*
.6
9
.8
0
.9
3
7.
 
W
hi
ch
 co
nd
iti
on
s o
r a
bn
or
m
al
iti
es
 ca
n 
be
 d
et
ec
te
d 
w
ith
 in
va
si
ve
 
pn
d?
.5
8
.6
5
.6
8
.6
9
.8
0
.5
0*
8.
 
W
ha
t i
s a
 p
os
si
bl
e 
ad
va
nt
ag
e 
of
 in
va
si
ve
 p
re
na
ta
l t
es
tin
g 
fo
r a
 p
re
g-
na
nt
 w
om
an
 a
nd
 h
er
 p
ar
tn
er
?
.8
8
.8
9
.8
8
1.0
0
1.0
0
.7
9
9.
 
W
ha
t i
s a
 p
os
si
bl
e 
ad
va
nt
ag
e 
of
 n
ip
t 
fo
r a
 p
re
gn
an
t w
om
an
 a
nd
 h
er
 
pa
rt
ne
r?
.8
0
.8
4
.8
2
.8
5
.8
0
.9
3
To
ta
l k
no
w
le
dg
e 
sc
or
e
7.9
7
8.
27
7.8
6
8.
23
8.
00
7.9
3
N
ot
e. 
C
 =
 C
ou
ns
el
lo
r. 
Fo
r e
ac
h 
ite
m
 0
 =
 in
co
rr
ec
t a
nd
 1 
= 
co
rr
ec
t. 
Th
e 
ra
ng
e 
of
 th
e 
to
ta
l s
co
re
 is
 0
 to
 9
. 
* =
 si
gn
ifi
ca
nt
 d
iff
er
en
ce
Ta
bl
e 
4.
 M
ea
n 
m
ic
 K
no
w
le
dg
e 
sc
or
es
 b
et
w
ee
n 
co
un
se
llo
rs
. S
ig
ni
fic
an
t d
iff
er
en
ce
s o
n 
ni
pt
 o
r i
nv
as
iv
e 
pn
d 
qu
es
tio
ns
 a
ns
w
er
ed
 co
rr
ec
t w
er
e 
ob
se
rv
ed
 
be
tw
ee
n 
co
un
se
llo
rs
 a
nd
 m
ar
ke
d 
w
ith
 *.
141
the impact oF counSellor characteriSticS on uptaKe
Discussion
Prenatal genetic counselling has become increasingly demanding due to the 
more complex information resulting from technological progress. Consequently, 
for pregnant women and their partners, the decision-making process may be un-
der more pressure than ever before. Such pressure requires thorough, high quali-
ty counselling. Assuming all counsellors commit to the recommendations made 
by the Dutch Health Council14 in their counselling, overall uptake ratios and the 
counsellors’ views on the content and approach of their counselling should be 
approximately equal in the grand total. All counsellors in our study provide and 
discuss the relevant information that is necessary to meet the first requirement 
of informed decision-making, which was validated by the high knowledge scores 
of pregnant women. However, in this study we found differences between coun-
sellors in their level of patient-centeredness, non-directivity, and the test uptake 
of patients.
Regarding patient-centeredness, some counsellors stated that they actively 
explore the patient’s values and attitudes, whereas others were less inclined to 
address the patient’s feelings and cognitions about the test options of nipt and 
invasive pnd (as illustrated by the quotes). The patient-counsellor relationship 
(e.g., affective communication, collaboration, goal consensus, positive regard) 
accounts for a substantial part of the psychological outcomes in a prenatal care 
trajectory.2, 15–17 We therefore consider this category to be of great importance. 
Providing space for patients to share their considerations and thoughts leads to 
a greater level of perceived patient-centeredness.2 It is important for counsel-
lors to provide guidance by eliciting information from their patients about their 
needs and by asking questions about their values and attitudes. Individual differ-
ences require counsellors to adjust, i.e. personalize, their counselling.
Regarding how counsellors valued non-directivity, we observed differences 
between counsellors, as indicated by their quotes. Although the concept of (non)
directivity has been used for more than four decades, there is still no consensus 
about the definition of directiveness and non-directiveness. Kessler has argued 
that not being directive is not the same as being non-directive.3, 5 He states that 
being directive involves a degree of persuasive coercion. However, the absence 
of persuasive coercion does not imply non-directivity. Non-directiveness is an 
active strategy that requires counselling skills that aim to support the patient’s 
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autonomy and self-directedness and provides them with a way of thinking about 
their considerations. According to Evans, a misunderstanding of the concept of 
non-directivity may lead the counsellor to adopt a stance of passivity or defen-
sive avoidance rather than engaged neutrality.18
Moreover, counsellors might be unaware of their directiveness.3 In our study, 
counsellors’ quotes show that a framing effect may implicitly be present in their 
counselling. For example, when they spend more time discussing one test than 
discussing the other. Differences in risk communication also become apparent 
from the interview quotes. Some counsellors frame their information by using 
words such as ‘negligible’, ‘only 1/1000’, and ‘extremely small’ when commu-
nicating the miscarriage risk. Other counsellors make it much more personal by 
stating that ‘the risk is small, but when it happens, it is a great tragedy’.
Furthermore, all counsellors are about the same age (42–51 years) and have 
been active in their profession for a long time. For them, invasive testing has been 
the standard of prenatal genetic testing for years. This may lead some of them to 
describe invasive pnd as such, while the testing options of either nipt or pnd 
are essentially different, since they have been designed for different purposes; 
invasive pnd is a diagnostic test, while nipt is a screening test. Counsellors also 
indicated that a substantial number of patients already have a strong preference 
for nipt when they enter the counselling. As the counsellors reported, the infor-
mation that is provided to them by primary or secondary care is often framed, 
shaped, or even flawed in favor of nipt. This skewed level of prior knowledge 
may motivate some counsellors to elaborate more on both test options and to bal-
ance the knowledge of their patients. However, other counsellors may become 
demotivated, as they feel like they are repeatedly making up for other referrers’ 
misconceptions. These matters of word choice and non-verbal communication 
may unintentionally steer the decision-making process of patients, which is 
hard to prevent. However, this framing effect may be counterbalanced by skillful 
counselling.
Counsellors in our study differed in the percentage of their patients opting for 
invasive pnd and nipt. Moreover, there was a group of patients who had an im-
pression of their counsellor’s preference for either test. The unique offer of high 
resolution microarray may incline the counsellors to guide their patients towards 
opting for invasive pnd. The finding that nearly 20% of pregnant women opted 
for invasive pnd in Erasmus Medical Center, compared to about 3% nationwide, 
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may indicate such a tendency. However, there is also contradictory data suggest-
ing that the difference in uptake cannot be explained by the unique offer. This 
data was retrieved from non-academic centers in the region that offered the 
same high resolution Snp array to their patients by sending their genetic material 
to the Erasmus Medical Center’s lab for chromosomal examination at submicro-
scopic level.7 Remarkably, none of these pregnant women who were offered the 
same options as in Erasmus Medical Center chose invasive pnd.7 Whether the 
impression of the counsellor’s preference had influenced the pregnant woman’s 
eventual decision needs to be further investigated.
This study gave a first exploration of counsellors’ differences affecting pa-
tients’ choice. We combined both qualitative data from the interviews with coun-
sellors and quantitative data of patients. Although we found differences in pa-
tient-centeredness and non-directivity between counsellors, we were unable to 
link these differences to differences in patients’ test uptake. It may be that the 
differences in counsellor characteristics are too subtle to identify a clear pattern 
related to patients’ choice based on such a limited number of counsellors. Also, 
counsellors’ answers may have been subjected to what they thought was socially 
desirable. We suggest that further research finds a way to study the actual coun-
selling provided by means of analyzing recorded counselling sessions in a larger, 
more powerful research design, to gain more insight into counsellors’ approach 
and content. Also, given the higher invasive pnd uptake rate in the Erasmus 
Medical Center compared to other academic centers, it would be interesting to 
compare counsellor approach and counselling content between different aca-
demic centers and/or hospitals.
Implications
Counsellors differed in their prenatal genetic counselling approach and content. 
Our results indicate that the information provision during counselling is suffi-
cient. Patient-centeredness differs between counsellors and may be improved by 
putting more emphasis on exploring patients’ meaning and personal significance 
during the counselling. We advocate that this theme should be elicited in training 
modules for counsellors. Another important theme to emphasize during training 
modules is the paradigm of non-directivity. The understanding of this concept 
should shift from emphasizing what counsellors should not do, i.e. persuasive 
coercion and giving advice, possibly inducing passivity, to what they should do, 
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i.e. promoting patient’s autonomy and self-directedness by aiming for patients to 
feel understood, in control, and competent. The latter involves an active attitude 
and requires more counsellor skills.
Conclusion
To conclude, patients’ choice ratio for either nipt or invasive pnd differed sig-
nificantly per counsellor. The different choice ratios of nipt/pnd could not be 
explained by different levels of patients’ knowledge or demographic factors, 
indicating that the approach and content of the counselling affect the eventual 
choices that patients make. In our study, counsellors seem to influence the choic-
es their patients make. It is important that counsellors reflect on their potential 
impact on the patients’ decision-making process. A framing effect may uninten-
tionally steer the decision-making process of patients, which is hard to prevent. 
The challenge remains to affect the decision-making process in the most posi-
tive and skillful manner; to facilitate well-deliberated and informed choices, to 
determine the counselling needs of pregnant women and their partners, and to 
promote autonomy and self-directedness.
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Answers to the research questions
The aim of this thesis is to address the psychological consequences of new tech-
niques which lead to a much larger scope of possible prenatal genetic findings for 
pregnant couples. In Chapter 1, the research questions were formulated. Below, 
these research questions are answered.
Part 1:
1. What do pregnant women, or couples choose; a broad or narrow scope 
of microarray regarding invasive PND? Do they wish to be informed of 
uncertain outcomes?
In Chapter 2 it is shown that an overwhelming majority of couples choose 
for a maximum of genetic information about their child, including uncertain 
outcomes.
2. Are there differences between participants opting for broad or narrow 
microarray regarding: the level of informed choice, anxiety and doubts?
There were no differences in informed choice and anxiety, but participants 
opting for broad microarray have more doubts (Chapter 3).
3. What is the psychological impact on parents of receiving uncertain out-
comes from invasive prenatal diagnosis?
Initially parents were worried, but no sustained negative psychological im-
pact was observed in this study. Note that this finding is under the condition 
of extensive post-test genetic counselling (Chapter 4).
Part 2:
1. What do pregnant women or couples choose; NIPT or invasive PND?
We found that in non-academic hospitals all couples chose nipt, whereas in 
the academic hospital 20% of patients opted for pnd (Chapter 5). This sug-
gests that: 1) there is a substantial group of pregnant women or couples with 
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interest in broad scope testing; 2) there are differences in counselling between 
the academic and non-academic hospitals.
2. Are there differences between participants opting for NIPT or PND re-
garding: the level of informed choice, anxiety and doubts?
Consistent with the findings reported in Chapter 3, no differences were ob-
served in informed choice and anxiety, but participants opting for pnd had 
more doubts. It seems that both groups of patients were equally informed and 
felt more or less the same. Patients possibly receiving more detailed genetic 
information were however a little bit more ambivalent about their choice.
3. Are there differences between women or couples who are counselled 
in the non-academic vs. academic hospitals regarding their choices for 
NIPT or PND?
Chapter 5 showed that the choice for either nipt or pnd was related to attend-
ing a non-academic vs. an academic hospital. In the non-academic centers, 
none of the women included in the study sample opted for invasive pnd, 
whereas in the academic hospital almost 20% of all participants did. This 
could be due to differences in counselling, patient characteristics, or coun-
sellor characteristic.
4. Do counsellors differ in the content and approach of their counselling 
regarding the level of information-centeredness, patient-centeredness, 
and the level of non-directivity?
The content of the counselling was more or less equal, however the approach 
and specifically framing of information and the communication of risks did 
differ between counsellors (Chapter 6).
5. To which extent does counsellors’ preference for NIPT/PND affects 
patients’ choice?
While counsellors’ preference has limited influence, in Chapter 6 it was 
shown that framing of information affects patients’ choice.
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6. Were patients aware of the counsellors’ preference?
Yes, a small percentage of patients felt that the counsellor had a preference, 
see Chapter 6.
7. Were there differences in patients’ knowledge and attitude scores be-
tween counsellors?
Overall, patients had very high knowledge scores, however, at the level of in-
dividual items related to knowledge of nipt or pnd there were differences 
between counsellors. This shows that counsellors place different emphasis on 
information provision of either nipt or pnd.
The fear for information
The increasing scope of possible findings in genetic testing has led to a debate re-
garding the attainability of making informed choices among health professionals 
and ethicists.
As the number of possible outcomes increases, it may become difficult for 
patients to understand the characteristics of the test and its implications.1, 2, 3, 4, 5 
This increasing scope with added complexity of information may jeopardize 
counselling and might subsequently influence the informed decision making 
process.3, 5–8 In the field of prenatal genetics, professionals fear that pregnant 
couples will suffer psychological burden because of informational overload 
due to new technological developments. According to de Jong et al. (2013)9 and 
Dondorp et al. (2015),10 the use of new, increasingly advanced techniques which 
provide much more genetic information about the fetus, may further hinder in-
formed choices. Making an informed choice is a prerequisite for reproductive 
autonomy. Marteau et al. (2001) state that ‘An informed decision is one where 
all the available information about the health alternatives is weighed up and 
used to inform the final decision; the resulting choice should be consistent with 
the individual’s values.10 An effective decision is one that is informed, consist-
ent with the decision-maker’s values and behaviourally implemented’ (p. 100).11 
Well-informed choices have been reported as psychologically beneficial.6, 12 
Psychological management of prenatal test decisions is better when knowledge 
is adequate, while uninformed choices increase decisional conflict and decrease 
feelings of personal wellbeing.13 These findings were not supported by the re-
sults of Chapter 3, where women that made uninformed choices had the same 
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level of anxiety and doubts as women that made informed choices. Interestingly, 
women who made an informed choice opted for broad scope testing more often.
Women who were at elevated risk of a fetus with a common trisomy such as 
Down’s syndrome or Patau or Edwards syndrome could opt for either prenatal 
screening (pnS) or prenatal diagnosis (pnd). In Chapter 2, we studied both hy-
pothetical and actual choices regarding the scope of the prenatal test. We did so 
by including women who, only opted for pnS. These women were viewed as the 
hypothetical group; we asked them to think about their desired scope of pnd if 
they would engage in pnd in the nearby future. The other group, women opting 
for pnd, made an actual choice regarding the scope of their prenatal microarray 
that was performed by our laboratory in real-time.
Women and their partners had a strong preference for broad information
New techniques in prenatal testing are developing rapidly. As a result, a much 
broader scope of information has become available for pregnant women with 
an increased risk after first trimester screening. The question was, however, if 
women and their partners would be interested in such broad scope information 
that might also reveal pathogenic findings not related to the indication, genetic 
variants with incomplete penetrance and variable phenotype associated with a 
susceptibility for neurodevelopmental disorders; susceptibility loci (Sl). In this 
thesis, pregnant couples could opt-in for disclosure of Sl in a research setting. 
Were pregnant couples inclined to obtain all genetic information that is available, 
or are they interested in less detailed information? When given the choice in the 
context of this thesis, almost all women choose for the widest scope of genetic 
information. Almost all women opting for invasive pnd chose to be informed of 
all findings, including uncertain findings. This finding is not supportive of the 
reluctance expressed by professionals and ethicists who fear that the disclosure 
of such findings might be too burdensome for the pregnant women and their 
partners. Interestingly, when offered as a hypothetical option, pregnant women 
were less inclined to all genetic information about their child. The main motive 
for women choosing pnd was to prepare for the future as much as possible. In the 
pnS group, women were less inclined to obtain all information about their fetus. 
This finding might be explained by the fact that women in this group do not, or 
do not yet, have such a strong need for information and certainty; hence their 
choice for prenatal screening which is only an estimation of risks and the fact that 
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it does not provide a diagnosis. Many of the research in the field of prenatal test-
ing is performed with hypothetical questions for participants. Chapter 2 showed 
that hypothetical choices are not a good predictor of real, eventual choices that 
patients will make.
Informed choices in the light of prenatal testing options
Prenatal genetic screening and follow-up diagnostic testing confront pregnant 
women with often difficult decisions. One of the first decisions women make is 
whether or not to participate in prenatal screening. When deliberating whether 
or not to participate in prenatal screening programs, many women may find it 
difficult to understand the characteristics of the test, to weigh its benefits and 
risks and to grasp the possible implications.14 In the Netherlands, only 27% of 
women engaged in prenatal screening in 2014. This is a lot lower than in, for ex-
ample, France or Denmark, where the uptake of first trimester combined testing 
is >90%. After the introduction of nipt in the Netherlands, the uptake of pre-
natal screening has increased to around 45% (trident-2, 2017).
The value of microarray in fetuses who were prenatally diagnosed with ultra-
sound anomalies has been widely accepted,15, 16 but its implementation for other 
indications has raised concerns among health care professionals, causing much 
debate regarding the disclosure of susceptibility loci.3, 17, 18 Some argue that these 
findings should be withheld from pregnant women in order not to burden them, 
while others state that withholding information is paternalistic and should be 
avoided.3 In our study participants who were disclosed an Sl reported no neg-
ative psychological impact with the prenatal diagnosis and disclosure of Sl on 
participants. They showed no enduring worries and unanimously indicated that 
pregnant couples should have an individualized pre-test choice about susceptibili-
ty loci (non)disclosure. It should be noticed that a key factor in mitigating parental 
anxiety with Sl disclosure appears to be post-test genetic counselling. Yet, the re-
silience of patients should not be underestimated. Throughout this thesis, women 
and their partners consistently showed a strong preference for the broadest scope 
of information, even including uncertain outcomes which will not surely lead to 
an aberrant child now, or in the future.
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The problem with measuring attitude in the context of informed choice
Traditionally, both knowledge, attitude and test choice are used when determin-
ing an informed choice. Our results showed that measuring attitude towards test-
ing with nipt or pnd was not suitable for this kind of testing offer.
The multidimensional measure of informed choice (mmic, as formulated by 
Michie et al. 2002) is a commonly used instrument in the prenatal testing en-
vironment. Michie et al. argue that the attitude towards testing and the act of 
engaging in a prenatal test should be congruent. This is self-evident in the case 
of not testing versus testing (0 versus 1), for instance whether or not to engage 
in prenatal screening. However, in the case of one specific test versus another 
specific test (nipt versus pnd), the attitude is not just about ‘getting information 
about the health of the fetus; yes/no’, but also about ‘the scope of the information’ 
and ‘the risk of a miscarriage’. In that case, attitude is no longer a unidimensional 
trait, but a complex mix of attitudes about different topics. There is no logical 
argument whether a choice for nipt or pnd based on these measured attitudes 
are a consistent choice or an inconsistent choice. For instance, if a woman is in-
clined towards more information about the health of the fetus, but prefers a test 
that is completely safe, she could have a positive attitude towards obtaining a 
broad scope of information but still choose nipt. Based on this thesis and earlier 
studies, we also suggest adding a deliberation scale to new measures of informed 
decision-making. According to van den Berg et al. (2005), deliberation is an eval-
uation of the alternatives, a process of deliberation about the alternatives and 
weighing up their pros and cons against each other. Bakkeren et al. are current-
ly developing a new measure based on the Measure of Informed Choice from 
Chapter 3 of this thesis, that adds a deliberation scale for the choice between 
nipt and invasive pnd.
Safety for the fetus overrides ‘the need to know’
Interestingly, after the introduction of non-invasive prenatal testing, women’s 
choices have changed substantially. Before its’ introduction, women unanimous-
ly opted for broad scope information. Many women stated; ‘why would I opt to 
know less, when I can opt to know more?’. However, the number of invasive pro-
cedures has strongly decreased since the introduction of nipt in April 2014. As 
much as 80% of all women in the Erasmus mc opted for nipt instead of pnd 
with a broad genomic microarray. It turned out that safety for the fetus overrides 
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the need to know. Women thus place a much higher priority on not being at risk 
of a miscarriage, even if it means that they will potentially miss important ge-
netic information about their fetus. It was the fear of a miscarriage associated 
with invasive procedures that made most women prefer nipt over invasive pnd. 
Most pregnant women and their partners choosing nipt did not refer to the lim-
ited scope of testing (trisomies 21, 13 and 18 only) as a motive for choosing nipt. 
Rather, for most respondents, safety concerns were the single most decisive fac-
tor. However, 87% of the participants choosing nipt would have wanted more 
information about other chromosomal aberrations and indicated they preferred 
a wider scope than is currently offered with nipt. Our findings suggest that most 
women are not making value-inconsistent choices but rather experience value 
ambivalence; tension between wanting to obtain as much information as possi-
ble and on the other hand to warrant the fetus’ safety. Our finding that women’s 
informational need is high, is consistent with our earlier studies and other re-
search.14, 19, 20 The broader informational need of women should be taken into 
account with future techniques such as Whole Exome Sequencing (WeS), which 
will potentially reveal even more genetic information about the unborn child. 
Due to the invasive nature of WeS, not many pregnant women will opt for this 
due to wanting to be at risk of a miscarriage. Should they engage in WeS, they are 
interested in obtaining as much information as possible.
Women and partners wanted maximal autonomy regarding their choice
Prenatal genetic counselling has become increasingly demanding due to the 
more complex information resulting from technological progress. Consequently, 
for pregnant women and their partners, the decision-making process may be un-
der more pressure than ever before. Health professionals have different views on 
what to offer pregnant women. Should the offer of prenatal testing be restricted 
or are women or couples able to make individualized choices? Throughout this 
thesis, women and their partners have voiced that it is very important to them 
to make their own, individual choices, and to exert maximal autonomy over this 
choice; whether it be nipt, invasive pnd or no further testing.
The influence of the counsellor on patient choices
Because of the recent developments in the field of prenatal genetic testing, 
more testing options have become available for pregnant women. Counsellors 
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are challenged to comprehensively discuss the complex information in a 
non-directive, i.e. autonomy promoting, and patient-centered manner that al-
lows patients to make an informed decision. These aspects are clearly desired, 
but they also require a much broader set of counselling skills. The counsellor is 
not only there to inform, but also to elicit information from patients and to use 
this information to guide the counselling session.21, 22 We explored the level of 
information-centeredness, patient-centeredness and level of non-directivity be-
tween principal prenatal counsellors of the Erasmus Medical Centre and found 
significant differences between counsellors (Chapter 5). Patients’ choice ratio for 
either nipt or pnd differed significantly per counsellor, indicating that the ap-
proach and content of the counselling affects the eventual choices that patients 
make. It should be noted that knowledge was very high in all groups of patients, 
indicating the counselling was of good quality. The different choice ratios of 
nipt/pnd could thus not be explained by different levels of patients’ knowledge, 
differences in attitude towards prenatal testing, or demographic factors such as 
previous pregnancies. This thesis showed that counsellors are not non-directive, 
nor are neutral and seem to influence the choices their patients make. And that 
this especially applies with regards to a ‘framing effect’ of the information about 
prenatal testing such as risk communication. It is important that counsellors are 
aware of their potential impact on patients’ decision-making processes.
The future: prenatal whole exome sequencing
The obvious next step in prenatal testing seems Whole Exome Sequencing (WeS). 
With WeS, it is possible to detect many more genetic changes, while the signifi-
cance of much of this information is yet unknown. Not all genetic changes affect 
the health of the unborn child, and some changes will only result in late-onset dis-
eases. Throughout this thesis, pregnant women and their partners had a strong 
wish to decide about the diagnostic scope of their genetic test. And, when given 
a choice, most pregnant couples opted for a maximum of information. However, 
WeS at this moment can only be offered in an invasive setting. The fact that an 
invasive procedure is necessary to perform a WeS might lower the choice for WeS 
substantially as we learned that women opt for the test with the lowest change on 
a spontaneous abortion.
If pregnant couples still are interested in the offer of prenatal WeS it needs a 
different protocol. Almost all women opted to be informed of uncertain outcomes 
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too (Chapter 2). In this light, it is expected that in the future pregnant couples 
would also tolerate and even prefer to be informed of uncertain outcomes from 
WeS. However, due to the almost infinite range of outcomes from WeS, it will 
not be possible to prepare pregnant couples for specific unfavorable outcomes. 
Thus, the question shifts to a more generic one; ‘do prospective parents want to 
know if there is an increased chance that their child may have a genetic condi-
tion?’(Riedijk, Galjaard & Tibben, in preparation, 2018). With WeS, counselling 
needs to be more focused on the individual’s tolerance for uncertainty and one’s 
view on what constitutes a satisfactory quality of life for a child with a condition. 
For counselling, there needs to be a shift from supplying information to a dis-
course about the pregnant couples’ personal values and attitudes.
Informed choice as process and as result
Throughout the studies in this thesis, women were capable of acquiring sufficient 
levels of knowledge. The information provided during counselling thus was com-
prehensible for participants. We did identify a problem with measuring attitude 
in the context of informed choices. The multidimensional measure of informed 
choice (mmic, as formulated by Michie et al. 2002) is a commonly used instru-
ment in the prenatal testing environment. Michie et al. argue that the attitude to-
wards testing and the act of engaging in a prenatal test should be congruent. That 
is self-evident in the case of not testing versus testing (0 versus 1), for instance 
whether or not to engage in prenatal screening. However, in the case of one 
specific test versus another specific test (nipt versus pnd), the attitude is not just 
about ‘getting information about the health of the fetus; yes/no’, but also about 
‘the scope of the information’ and ‘the risk of a miscarriage’. In that case, attitude 
is no longer a unidimensional trait, but a complex mix of attitudes about different 
topics. There is no logical argument whether a choice for nipt or pnd based on 
these measured attitudes are a consistent choice or an inconsistent choice. For 
instance, if a woman is inclined towards more information about the health of 
the fetus, but prefers a test that is completely safe, she could have a positive atti-
tude towards obtaining a broad scope of information but still choose nipt.
The attitude items are measured unidimensional, however, our qualitative 
data show that attitude is rather multidimensional. It is impossible to determine 
a score that synthesizes all the attitudes of women regarding prenatal testing in a 
‘positive-negative’ spectrum qualification.
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The safety of the test, i.e. not being at risk of a miscarriage, seems to be a 
single decisive factor for most pregnant women. In many cases, the safety for the 
fetus outweighs a broader informational need. Future multidimensional models 
should include such a criterion.
Recommendations for research
In the studies described in this thesis, the study population was a self-selected 
group of women who were willing to participate in scientific research on a volun-
tary, non-paid basis. It appeared that these women were mostly highly educated, 
of Dutch origin and non-religious. However, it may very well be that in a more 
diverse group of pregnant women, the preference for the scope of information 
and their counselling needs are different. Therefore, I propose that further re-
search should focus on acquiring different populations of pregnant women and 
their partners.
It would also be interesting to develop a model that looks at new ways of how 
to determine the counselling needs of different groups of patients. Because of 
lower education, comprehension of the information provided during counselling 
could also be more limited, resulting in lower knowledge scores.
With regards to measuring informed decision-making, we think it is impor-
tant to include a deliberation scale to the measure. This could help to get a better 
insight in the way choices are made, since measuring only knowledge and atti-
tude is not sufficient when measuring between types of a test, instead of whether 
or not to engage in a test. Lastly, in Chapter 5 differences between counsellors 
were revealed, showing that the patient uptake of invasive pnd was different be-
tween counsellors. Despite the counsellors preference being obvious to the pa-
tients, all of the women were supported by the counsellor and had acquired suffi-
cient knowledge about nipt or invasive pnd. This thesis showed that counsellor 
preference is not harmful for patients, as long as proper counselling and infor-
mation provision and sufficient patient knowledge is warranted. These findings 
were based on self-reported answers to semi-structured interviews of a small 
sample of counsellors, but doing a large-scale analysis of actual counselling con-
versations would be thoroughly interesting. We advocate for the development of 
skills training for counsellors and clinicians, in order to safeguard the principles 
of proper non-directivity and/or shared decision-making.
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Implications for clinicians & healthcare policy
In 2017, approximately 55% of pregnant women did not opt for prenatal screen-
ing, whereas 45% of women did (trident-2, 2017). If they decide to engage in 
prenatal testing, women want to make their own choices regarding their prena-
tal test and its’ scope, and most prefer a maximum of genetic information about 
their child. Even more so, most want to be informed of uncertain outcomes, de-
spite the more conservative view of professionals to not disclose such informa-
tion. This thesis shows that facilitating deliberation during counselling is very 
important. We advocate that attitude and deliberation should be elicited in train-
ing modules for counsellors. Another important theme to elicit during training 
modules is the paradigm of non-directivity. The understanding of this concept 
should shift from emphasizing what counsellors should not do, i.e. persuasive 
coercion and giving advice, possibly inducing passivity, to what they should do, 
i.e. promoting patient’s autonomy and self-directedness by aiming for patients 
to feel understood, in control, and competent.
This thesis showed that disclosing broad scope genetic information to preg-
nant women was not psychologically harmful. In fact, most women had excellent 
understanding after pre-test counselling. Doubts about the choice were some-
what higher in the group of women that opted for a maximum of genetic informa-
tion about their baby. However, it remains unclear if these women were not more 
doubtful beforehand, which led them to choose a broad scope test.
Under the current conditions of proper pre-test genetic counselling, this the-
sis showed throughout that disclosing broad scope information is something 
pregnant women want, choose, and can cope with. The existent safeguards of 
counselling function excellently. There is no need to worry that pregnant women 
cannot deal with broad scope information. Even more so, if genetic information 
would be expanded in the case of prenatal WeS, it is expected that patients will 
be able to manage this.
Concluding, if proper counselling is warranted, the scope of prenatal genet-
ic information can be further expanded. In any case, patients should be able to 
make their own choices for a prenatal test and its’ scope.
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Summary
Prenatal genetic testing informs pregnant couples about health problems of their 
unborn child. The knowledge prenatal genetic testing generates may improve 
pregnancy care. In case of abnormal findings, it may also cause pregnant couples 
to decide about ending or continuing their pregnancy.
Over the last 10 years the possibilities for genetic testing in pregnancy have 
developed rapidly. Since the introduction of new techniques such as microarray 
analyses for invasive prenatal diagnosis (pnd), the scope of possible findings 
from a prenatal test has increased at greatly. Since 2014, non-invasive prenatal 
testing (nipt) has been introduced in the Netherlands. With nipt, it is possible 
to test for common trisomies with a high probability, at no risk of a miscarriage. 
nipt is offered as an alternative for invasive pnd. Microarray and nipt created 
a new landscape of choices for pregnant women. This thesis explored this new 
landscape from both the patient and the health care professionals’ perspective.
The main objectives of this thesis are formulated in Chapter 1 as; 
1. Assess the choice between broad or narrow scope microarray in invasive 
pnd, and compare participants regarding the level of knowledge, anxiety 
and doubts, 
2. investigate what the psychological impact of receiving uncertain prenatal 
outcomes is on prospective parents, 
3. assess the choice between nipt and invasive pnd, and compare participants 
regarding the level of knowledge, anxiety and doubts and 
4. investigate whether prenatal counsellors differed in the content and ap-
proach of their counselling, and if patients made different choices per 
counsellor.
In Chapter 2 we discuss the choice for a broad or narrow scope of microarray 
in invasive pnd. Consensus regarding the scope of invasive prenatal diagnosis 
(pnd) pregnant couples should be offered is lacking. Chapter 2 examined preg-
nant couples’ preferences, doubts and satisfaction regarding the scope of invasive 
pnd. A striking 95% of patients opted for broad scope array, including disclosure 
of uncertain results such as susceptibility loci. Ninety percent was satisfied with 
their choice and wished to decide about the scope themselves. Concluding, the 
majority of patients wanted to obtain as much information as possible, and high-
ly appreciated the offer of an individualized choice. It therefore seems justified 
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to offer patients a choice; in both the scope of microarray and for the disclosure 
of uncertain outcomes such as susceptibility loci.
Chapter 3 investigates the choice between broad or narrow scope micro array, 
and assesses whether women that were offered this choice had sufficient knowl-
edge and a consistent attitude. We found that both groups of women had equal 
knowledge. Knowledge was high among all participants in the study. However, 
attitude consistency was more complicated since not all women chose a test 
that was congruent with their attitude. While previous studies demonstrat-
ed that knowledge is an important component in informed decision-making, 
Chapter 3 underlines that a consistent attitude might be equally important for 
decision-making. Chapter 3 advocates more focus on attitude-consistency and 
deliberation during counselling as compared to only a strong focus on knowledge.
Chapter 4 takes a closer look at women and partners that actually received un-
certain prenatal test outcomes, and aimed to assess the psychological impact of 
such findings. Since there were only few patients who had such a disclosed result, 
Chapter 4 provides a first insight of parents’ experiences through semi-structured 
interviews with 13 participants. All participants reported feeling overwhelmed by 
the test outcome initially. After the initial shock, all participants seemed not to 
have enduring psychological burden. All but one participants would opt to be in-
formed of these findings again in the future. Chapter 4 concludes that the resil-
ience of patients should not be underestimated.
In Chapter 5 we discuss the choice between nipt and invasive pnd for wom-
en with an increased risk based on first trimester screening. nipt is safer than 
pnd, but has a limited scope for only trisomies 21, 13 and 18. We studied patients’ 
choices for nipt or pnd, whether these choices were informed, and if were differ-
ences in level of knowledge, anxiety and doubts between patients opting for nipt 
or pnd. Our results show that in the academic hospital, 82% chose nipt and 18% 
chose invasive pnd. In the non-academic hospitals, all women chose nipt. A big 
difference. The main motive for choosing nipt was safety for the fetus. The main 
motive to choose pnd was its reliability and faster disclosure of results, and to ob-
tain more information. Women who chose pnd were not more anxious, but had 
a higher level of doubts. Eighty-seven percent of women electing nipt indicated 
they preferred a wider scope, were it not for the risk of miscarriage associated 
with pnd. Concluding, Chapter 5 shows that for most women, safety for the fetus 
overrides ‘the need to know’.
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Chapter 6 describes non-directivity and the influence of the counsellors’ pref-
erence on patient choices in prenatal genetic counselling. Counsellors are chal-
lenged to comprehensively discuss the complex information in a non-directive, 
i.e. autonomy promoting, and patient-centered manner that allows patients to 
make an informed decision. Semi-structured interviews with four senior ob-
stetricians and one senior nurse were held regarding how they value provision 
of information, adopt a patient-centered attitude, and value non-directivity. 
Significant differences in nipt/pnd ratios of patient choices were observed 
between counsellors, with the largest difference being 35% versus 4% opting for 
invasive pnd. Between 9% and 22% of the patients had an impression of their 
counsellor’s preference and chose in accordance with this preference. Patients’ 
overall knowledge and attitude scores did not differ across counsellors. Thus, all 
patients were equally well-informed. In conclusion, the differences in nipt/pnd 
ratios between counsellors indicate that counsellor differences affect the choices 
their patients make.
Lastly, Chapter 7 provides an overview of our main findings, an interpretation 
of these findings and the implications for both clinicians and healthcare policy. We 
also added recommendations for future research. The studies in this thesis have 
added insight into the patients’ perspective in the ever changing prenatal testing 
environment. We addressed the psychological consequences of new techniques 
in prenatal testing for pregnant women and their partners. The main message of 
this thesis is that patients want to make their own, individualized choices regard-
ing their prenatal test, and that most patients are capable of making such choic-
es. Concluding, if proper counselling is warranted, the scope of prenatal genetic 
information can be further expanded without psychological damage for patients.
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Prenataal genetisch testen biedt zwangere stellen de mogelijkheid om informa-
tie te verkrijgen over eventuele gezondheidsproblemen bij hun toekomstige kind. 
De kennis die prenatale testen kunnen opleveren, kan de zorg tijdens of na de 
zwangerschap bevorderen. Als er sprake is van afwijkingen, leidt de uitslag van 
een prenatale test voor sommige zwangere stellen tot de keuze om een zwanger-
schap al dan niet te beëindigen.
De afgelopen 10 jaar hebben de mogelijkheden voor prenatale testen zich in 
een razend tempo ontwikkeld. Sinds de introductie van nieuwe technieken, zoals 
microarray analyse voor invasieve prenatale diagnostiek (pnd), is de reikwijdte 
van mogelijke bevindingen enorm toegenomen. Daarnaast werd in 2014 Non-
invasief Prenataal Testen (nipt) geïntroduceerd in Nederland; een alternatief 
voor invasieve pnd, waarbij het mogelijk is om met een hoge voorspellende waar-
de op de drie meest voorkomende aandoeningen (Down, Edwards en Patau syn-
droom) te testen zonder het risico op een miskraam. Microarray analyse en nipt 
hebben een nieuw landschap van keuzes gecreëerd voor zwangere stellen. Dit 
proefschrift exploreert dit nieuwe landschap vanuit het perspectief van zowel de 
patiënt als de zorgverlener/counsellor.
De onderzoeksvragen van dit proefschrift zijn geformuleerd in Hoofdstuk 1 
als zijnde; 
1. Het onderzoeken van de keuze tussen een brede en een smalle reikwijdte 
van microarray bij invasieve pnd, en het vergelijken van patiënten op de 
mate van kennis, angst en twijfel, 
2. beoordelen wat de psychologische impact van onzekere prenatale resultaten 
is voor aanstaande ouders, 
3. de keuze tussen nipt en invasieve pnd onderzoeken, en patiënten ver-
gelijken op de uitkomstmaten van kennis, angst en twijfel en 
4. exploreren of prenatale counsellors verschillen wat betreft de inhoud en 
aanpak van hun counselling, en of patiënten andere keuzes maakten per 
counsellor.
In Hoofdstuk 2 wordt de keuze tussen een brede en smalle reikwijdte van mi-
croarray analyse bij invasieve pnd, en daarmee de beschikbare hoeveelheid in-
formatie over het ongeboren kind, nader belicht. Tot op heden is er nog geen con-
sensus bereikt over de reikwijdte van een test die zwangere stellen aangeboden 
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zouden moeten krijgen. Hoofdstuk 2 belicht de keuzes die stellen maakten, 
alsmede de twijfels over en tevredenheid met hun keuze. Het is opvallend dat 
maar liefst 95% van de patiënten kiest voor een brede reikwijdte van microarray, 
met alle informatie ínclusief onzekere uitkomsten, de zogenaamde susceptibility 
loci. Negentig procent was tevreden met hun keuze en wilde zelf beslissen over 
de reikwijdte van hun prenatale test. Concluderend wilde de meerderheid van 
de patiënten zoveel mogelijk informatie ontvangen over hun ongeboren kind. 
Bovendien vonden ze het aanbod om een gepersonaliseerde keuze te kunnen 
maken zeer prettig. Dit rechtvaardigt het aanbieden van een gepersonaliseer-
de keuze; zowel wat betreft de reikwijdte van de test als voor het prenataal ver-
melden van onzekere uitkomsten zoals susceptibility loci.
Hoofdstuk 3 bestudeert de keuze tussen een brede en smalle reikwijdte van 
microarray, en bekijkt of patiënten adequate kennis en een consistente attitude 
hadden. De uitkomst is dat beide groepen, dus zowel de groep die voor een brede als 
voor een smalle reikwijdte koos, evenveel adequate kennis hadden. Er was dus geen 
verschil in mate van geïnformeerdheid. Alle deelnemers (in beide groepen) hadden 
een zeer hoog kennisniveau. Qua attitude consistentie lag het gecompliceerder, 
omdat niet alle vrouwen een keuze maakte die overeenkwam met hun attitude ten 
opzichte van een prenatale test. Hoewel eerdere studies al aantoonden dat ken-
nis een belangrijke component is van geïnformeerde besluitvorming, benadrukt 
Hoofdstuk 3 dat een consistente attitude minstens even belangrijk is voor het maken 
van een goed geïnformeerde keuze. Het onderstreept het belang van meer aandacht 
voor het belichten van de houding en attitude van de zwangere zelf tijdens de coun-
selling, in plaats van enkel te focussen op het overbrengen van adequate kennis.
Hoofdstuk 4 zoomt in op zwangere stellen die daadwerkelijk een onzekere pre-
natale uitslag hebben gekregen, en brengt de psychologische impact van zulke 
bevindingen in kaart. Omdat er slechts een kleine groep patiënten was die een der-
gelijke uitslag hebben ontvangen, poogt Hoofdstuk 4 een eerste inzicht te geven in 
de ervaringen van 13 (aanstaande) ouders door middel van semi gestructureerde 
interviews. Alle deelnemers gaven aan in eerste instantie geschrokken te zijn van 
de uitslag. Na de eerste schok leken alle deelnemers geen langdurige psycholo-
gische schade opgelopen te hebben. Alle deelnemers, op één na, wilde in de toe-
komst graag opnieuw geïnformeerd worden over een onzekere prenatale uitslag. 
Hoofdstuk 4 concludeert dat de veerkrachtigheid van patiënten niet onderschat 
moet worden.
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Hoofdstuk 5 richt zich op de keuze tussen nipt en invasieve pnd in een groep 
vrouwen met een verhoogd risico op basis van eerste trimester prenatale scree-
ning. nipt is veiliger dan pnd, maar heeft een beperkte reikwijdte en test alleen 
op het syndroom van Down, Edwards en Patau. We bestudeerden de keuze tus-
sen nipt/pnd, of het geïnformeerde keuzes betrof, en of er verschillen waren 
in de mate van kennis, angst en twijfel tussen nipt/pnd. Onze resultaten tonen 
aan dat er in het academisch ziekenhuis (Erasmus mc) andere keuzes worden 
gemaakt dan in niet-academische ziekenhuizen. In een academische ziekenhuis 
setting koos 82% voor nipt en 18% voor invasieve pnd. In de niet-academische 
ziekenhuis setting kozen alle patiënten voor de nipt en dus 0% voor invasieve 
pnd; een groot verschil. Het meest voorkomende motief voor nipt was het 
ontbreken van een miskraamrisico c.q. de veiligheid voor het ongeboren kind. 
Vrouwen die voor invasieve pnd kozen, gaven aan dit te doen vanwege de ho-
gere betrouwbaarheid van de test, de snellere uitslagtermijn (2 vs. 3 weken), en 
de mogelijkheid om meer genetische informatie te verkrijgen. Vrouwen die voor 
invasieve pnd kozen waren niet angstiger, maar hadden wel een hogere mate van 
twijfel over hun keuze. Van de vrouwen die nipt kozen, gaf 78% aan geïnteres-
seerd te zijn in een bredere reikwijdte van de test, als er geen miskraamrisico aan 
verbonden zou zijn. Concluderend laat Hoofstuk 5 zien dat de meeste vrouwen 
bijzonder veel waarde hechten aan veiligheid voor het ongeboren kind, en deze 
veiligheid vele malen zwaarder weegt dan maximale informatie verkrijgen.
Hoofdstuk 6 beschrijft het principe van non-directiviteit en de invloed van 
de counsellor op de keuzes van patiënten in prenatale genetische counselling. 
Voor de counsellor is het een uitdaging om de complexe informatie op een be-
grijpelijke manier over te brengen. Dit moet op een non-directieve, autonomie 
bevorderende en patiëntgerichte manier, die zorgt dat patiënten een geïnfor-
meerde, weloverwogen keuze kunnen maken. Er werden semigestructureerde 
interviews gehouden met vier ervaren counsellors en één ervaren verpleegkun-
dige. Gevraagd werd hoe ze omgaan met het overbrengen van informatie, pati-
entgerichtheid en met non-directiviteit. Er waren significante verschillen in de 
verhouding nipt/pnd ratio’s tussen counsellors, met het grootste verschil van 
35% vs. 4% van de patiënten die kiest voor invasieve pnd. Van deze patiënten 
had 9% tot 22% het idee dat hun counsellor een voorkeur had, en maakte zij hun 
keuze voor nipt of pnd in overeenstemming met de voorkeur van de counsellor. 
De totale kennis en attitude scores verschilden niet significant tussen counsellors; 
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alle patiënten waren dus even goed geïnformeerd. Concluderend, de verschillen 
in nipt/pnd ratio’s laten zien dat counsellors de keuze van de patiënt wel dege-
lijk beïnvloeden.
Tot slot geeft Hoofdstuk 7 een overzicht van de bevindingen uit dit proef-
schrift, een interpretatie en de implicaties voor zowel clinici als gezondheidszorg-
beleid. Tevens doen we aanbevelingen voor toekomstig onderzoek. De studies 
in dit proefschrift bieden inzicht in het patiënten perspectief, wat heel belang-
rijk is in het snel veranderende milieu van prenataal testen. We onder zochten 
de psychologische consequenties van nieuwe technieken van prenataal testen 
voor zwangere vrouwen en hun partners. De belangrijkste boodschap van dit 
proefschrift is dat patiënten hun eigen, geïndividualiseerde keuzes willen maken 
en dat de meeste patiënten goed in staat zijn om dit te doen. Concluderend, als 
goede counselling gewaarborgd is én blijft, kan de reikwijdte van prenatale gene-
tische informatie verder worden uitgebreid zonder dat dit psychologisch schade-
lijk is voor patiënten.
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de progressie van mijn onderzoek. Tijdens mijn promotie is onze familieslogan 
zeker van toepassing geweest; when the going gets tough, the tough get going!
Mama, papa en broertje, bedankt voor jullie liefde, steun en goede zorgen. 
Jullie staan altijd voor me klaar met raad en daad. Toen ik mijn eerste huis kocht 
in 2016, de drukste periode van mijn PhD bestaan, hebben jullie me enorm ge-
holpen met de verbouwing en het klussen. Ik hoop dat ik later voor jullie mag 
zorgen, zoals er voor mij gezorgd is. Ik hou van jullie.
Dan nog mijn dierbare vriendinnen; Elin, Felicia, Hanne en Door, waarmee 
ik opgroeide. Vroeger nog tienermeisjes en nu (bijna) volwassen jonge vrouwen. 
Felicia, dank voor je betrokkenheid bij mijn promotietraject. Bij jou kon ik altijd 
terecht om mijn hart te luchten, je volgende m’n publicaties op de voet en wilde 
alle ins en outs van mijn academische avonturen weten.
Tot slot, mijn lieve Theo. Hoewel je pas als een van de laatsten insprong in 
mijn leven en mijn promotietraject, ben je in korte tijd ontzettend belangrijk 
voor mij geworden. Dankjewel voor je liefde & steun. Voor de mooie tijden die 
we samen al beleefd hebben. Voor het prachtige ontwerp van dit proefschrift; 
je hebt mijn levenswerk handen en voeten gegeven. Op naar de toekomst, samen 
met jou!
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PhD Portfolio
Name
Sanne Leanne van der Steen
Erasmus MC Department: Clinical Genetics
PhD period
November 2013 – December 2018
Promotors 
A. Tibben & J. van Busschbach
Supervisors
S.R. Riedijk & R.J.H. Galjaard
1. PhD training
Year Workload
Academic skills
Systematic Literature Retrieval in PubMed and other data bases, 
Endnote, Medical Library Erasmus MC 2013 1 ECTS
Biomedical English Writing and Communication 2014 4 ECTS
CPO course 2014 0.3 ECTS
BROK (Basic course Rules and Organization for Clinical researchers) 2015 1.5 ECTS
CPO course 2014 0.3 ECTS
Research Integrity 2015 2 ECTS
Presentations
ESHG/EMPAG Milan, Italy 2014 2 ECTS
ISPD Brisbane, Australia 2014 2 ECTS
ESHG Barcelona, Spain 2015 2 ECTS
NIPT Consortium Amsterdam, The Netherlands 2015 2 ECTS
NAGCC Utrecht, The Netherlands 2017 2 ECTS
International conferences
ESHG/EMPAG Milan, Italy 2014 2 ECTS
ESHG Barcelona, Spain 2015 2 ECTS
ESHG/EMPAG Copenhagen, Denmark 2017 2 ECTS
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Year Workload
Seminars and workshops
NACGG 2013 1 ECTS
VKGN 2014 1 ECTS
NACGG 2014 1 ECTS
ESHG/EMPAG 2014 1 ECTS
Workshop Grant writing 12C approach 2017 0.1 ECTS
Workshop elevation pitch 2017 0.1 ECTS
Other
 Journal Club, Department of Clinical Genetics, Erasmus MC 2013–2017 2 ECTS
2. Teaching activities
Lecturing
Psychological aspects of genetic counselling, BA2 (VO) 2014–2017 6 ECTS
Lecture Horizon study, minor Genetics in Society 2015–2017 2 ECTS
Lecture PhD trajectory, minor Genetics in Society 2015–2017 2 ECTS
Decisions regarding prenatal genetic testing, BA3 (VO) 2015–2017 6 ECTS
Bereavement; dealing with loss (VO), BA3 2015–2017 6 ECTS
Samenwerken (SW), BA1 2015–2017 8 ECTS
Consultvoering (CV), BA1–2 2015–2017 8 ECTS
Communicatie & Attitude (CA), BA3 2015–2017 4 ECTS
Arts Patient Contact (APC), BA3 2015–2017 4 ECTS
Workshop Genetic Counselling, minor Genetics in Society 2017 2 ECTS
Supervising practicals
Basic communication skills for medical students BA 1–3 2015–2017 8 ECTS
Supervising theses
Several bachelor & master theses for Horizon Study/
Clinical Genetics
2015–2017 6 ECTS
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List of publications
The psychological challenges of replacing conventional karyotyping with 
genomic Snp array analysis in prenatal testing.
 Published in Journal of Clinical Medicine, July 2014;3(3):713-23. doi: 10.3390/
jcm3030713.
Pregnant couples at increased risk for common aneuploidies choose maximal 
information from invasive genetic testing
 Published in Clinical Genetics, July 2015;88(1):25-31. doi: 10.1111/cge.12479.
The psychological impact of prenatal diagnosis and disclosure of susceptibility 
loci: first impressions of parents’ experiences
 Published in Journal of Genetic Counselling, December 2016;25(6):1227–1234.
Choosing between higher and lower resolution microarrays: do pregnant 
women have sufficient knowledge to make informed choices consistent with 
their attitude?
 Published in the Journal of Genetic Counselling, February 2018;27(1):85-94. doi: 
10.1007/s10897-017-0124-5.
Offering a choice between nipt and invasive pnd in prenatal genetic counsel-
ling: the impact of clinician characteristics on patients’ test uptake
 Published by the European Journal of Human Genetics, October 2018;
 s41431-018-0287-z.
Non-invasive or invasive prenatal testing: safety for the fetus overrides the need 
for broad scope genetic information
  Under review by Clinical Genetics
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Curriculum vitae
Sanne Leanne van der Steen was born in 1989 in The Hague, The Netherlands. 
After she graduated from the Montessori Lyceum in Rotterdam in 2006, she 
started to study Pedagogy & Child Development. During the first year, she found 
out she had a fascination for psychology in the broader sense. Therefore, she 
switched to studying Psychology at the Erasmus University Rotterdam in 2007. 
She specialised in Clinical Psychology, with a passion for Medical Psychology. 
She opted for a minor in Medical Psychology at the Erasmus Medical Center, 
where her interest in research and genetics started. 
Her bachelor minor led to an internship during her master phase. During the 
internship, she became involved in the Horizon Study of the Erasmus mc as a 
research assistant, which ultimately led to her position as a PhD student. In 2013 
she obtained her master’s degree in Clinical Psychology, and straight after she 
started working as a PhD student in the department of Clinical Genetics, under 
the wings of prof. dr. Aad Tibben and prof. dr. Jan van Busschbach. 
During the first PhD year in 2013, her main focus was on the inclusion of preg-
nant women for her research. She combined this with her work as a medical psy-
chologist at the outpatient clinic of Clinical Genetics. 
From 2013 onwards, she also got involved in teaching. In 2015 she became a 
university lecturer, training medical students and residents in genetic counsel-
ling and communication skills. She did this for both the Department of Medical 
Psychology & Psychotherapy and the Department of Clinical Genetics. 
In 2018 she became a psychologist in specialized mental health care (S-GGZ/
psychiatry) at Pameijer in Rotterdam. Her main focus is the psychological as-
sessment and treatment of multi-problem patients, of which some have an 
under lying genetic abnormality leading to i.e. cognitive impairment and neuro-
developmental/psychiatric problems. She wants to start a training to become 
a health care psychologist (Gezondheidszorgpsycholoog) and would love to be 
able to combine this with scientific research in the future. She hopes to remain 
curious and is always open to new ideas. 
The new era of prenatal genetic testing: Considerations regarding the 
scope, psychological consequences & pregnant couples’ preferences
Prenatal genetic testing informs pregnant couples about the possible health prob-
lems of their unborn child. Over the last 10 years the possibilities for genetic testing 
during pregnancy have developed rapidly. Since the introduction of new techniques 
such as microarray analysis for invasive prenatal diagnosis (pnd), the scope of pos-
sible findings from a prenatal test has increased greatly. In 2014, non-invasive pre-
natal testing (nipt) has been introduced in the Netherlands. With nipt, it is possi-
ble to test for common trisomies with a high probability, at no risk of a miscarriage 
i.e. safely. nipt is offered as an alternative for invasive pnd.
Both microarray and nipt created a new landscape of choices for pregnant 
women and their partners. This thesis addresses their preferences, the psycho-
logical consequences such as anxiety and doubts and the level of informed choice. 
The studies in this thesis have added insight into the patients’ perspective in the 
ever changing prenatal testing environment.
Sanne Leanne van der Steen (The Hague, 1989) obtained her master’s degree in 
Clinical Psychology in 2013, with a passion for Medical Psychology. At the Erasmus 
Medical Center in Rotterdam, her interest in research and genetics started, which 
ultimately led to this thesis.
Next to being a psychologist, she became involved in teaching as a university lec-
turer, training medical students in genetic counselling and communication skills at 
both the Department of Medical Psychology & Psychotherapy and the Department 
of Clinical Genetics of the Erasmus Medical Center in Rotterdam.
